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Background:	  Cryptorchidism	  is	  the	  most	  common	  anomaly	  in	  newborn	  boys.	  Despite	  its	  
frequency	  there	  are	  controversies	  regarding	  many	  aspects,	  including	  the	  optimal	  timing	  of	  
surgery,	   natural	   course	   of	   the	   spontaneously	   descended	   testes,	   frequency	   of	   acquired	  
cryptorchidism,	  risk	  of	  infertility	  and	  testicular	  cancer.	  Based	  on	  indirect	  proof	  the	  general	  
consensus	  is	  that	  treatment	  should	  be	  offered	  before	  the	  age	  of	  2	  years.	  However,	  this	  has	  
not	  been	  proven	  in	  prospective	  randomized	  trials.	  	  
	  
Aims:	  The	  objectives	  are	  to	  present	  the	  first	  prospective	  randomized	  study	  on	  the	  optimal	  
age	   for	   treatment,	   to	   identify	  markers	  of	   importance	   for	   future	   spermatogenesis	  and	   to	  
investigate	  the	  growth	  and	  natural	  course	  of	  the	  spontaneously	  descended	  testes.	  	  
	  
Patients	  and	  methods:	  A	  total	  of	  426	  boys	  were	  included.	  Morphometric,	  volumetric	  and	  
endocrine	  data	  were	  investigated	  in	  boys	  randomized	  to	  surgery	  at	  9	  months	  or	  3	  years	  of	  
age	  and	  compared	  to	  boys	  with	  spontaneous	  descent	  up	  to	  5	  years	  of	  age.	  A	  total	  of	  213	  
biopsies	  were	  analyzed,	   testicular	  volume	  was	  assessed	   from	  ultrasound	  measurements	  
at	   birth	   and	  6	  months	   and	   then	   yearly	  up	   to	  5	   years	   of	   age.	  At	   surgery,	  measurements	  
were	  made	  with	  a	  ruler.	  Inhibin	  B,	  LH,	  FSH	  and	  testosterone	  were	  analyzed	  at	  birth,	  at	  2	  
and	  6	  months	  and	  at	  1,	  2	  and	  4	  years	  of	  age.	  	  
	  
Results:	  Comparisons	  between	  early	  and	  late	  treated	  boys	  showed	  significant	  differences	  
in	   testicular	  growth,	  number	  of	  germ	  and	  Sertoli	   cells	   (p<0.001)	  at	   the	   time	  of	   surgery.	  
The	  testes	  that	  descended	  spontaneously	  showed	  impaired	  growth	  and	  were	  found	  to	  be	  
at	   high	   risk	   for	   later	   ascent.	   No	   conclusive	   differences	   in	   hormone	   levels	   were	  
demonstrated.	  	  
	  
Conclusions:	  We	  have	  proven	  that	  surgical	  treatment	  at	  9	  months	  of	  age	  is	  more	  
beneficial	  for	  spermatogenesis	  and	  testicular	  growth	  compared	  to	  treatment	  at	  3	  years	  
of	  age,	  testicular	  volume	  was	  also	  shown	  to	  reflect	  spermatogenesis	  in	  early	  childhood.	  
Hormones	  taken	  at	  infancy	  could	  not	  predict	  later	  testicular	  growth	  or	  spermatogenesis.	  
We	  proved	  that	  also	  spontaneously	  descended	  testes	  have	  impaired	  later	  growth	  and,	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Cryptorchidism	   is	   a	   condition	  where	   one	   or	   both	   testes	   fail	   to	   descend	   into	   the	  
scrotum	  and	   the	  most	   common	  anomaly	   in	  newborn	  boys.	  Despite	   its	   frequency	  
there	   are	   still	   controversies	   regarding	   many	   aspects,	   including	   etiology,	   natural	  
history,	  mode	  and	  timing	  of	  treatment	  as	  well	  as	  the	  risk	  of	  infertility	  and	  testicular	  
cancer.	  	  
	  
Almost	   all	   controversies	   are	   the	   result	   of	   a	   lack	   of	   standard	   definitions	   and	  
prospective	  long-­‐term	  follow-­‐up	  studies,	  which	  makes	  it	  very	  difficult	  to	  compare	  
results	  from	  the	  numerous	  studies	  done	  on	  cryptorchidism.	  
	  
There	   is	  a	  general	   consensus	   that	   the	  condition	  should	  be	   treated	  early	   in	   life	   to	  
reduce	   the	   risk	  of	   infertility	  and	   testicular	   cancer.	  However	   in	   reality,	  we	  do	  not	  
know	   whether	   or	   not	   treatment	   in	   early	   infancy	   reduces	   the	   risk	   of	   testicular	  
cancer	   or	   to	  what	   extent	   fertility	   is	   improved,	   especially	  when	  only	   one	   testis	   is	  
affected.	   Is	  surgery	  performed	  only	   to	  make	   it	  easier	   to	  detect	  a	   future	   testicular	  
cancer	  and	  for	  cosmetic	  reasons	  in	  these	  cases?	  
	  
The	  proper	  timing	  of	  surgery	  has	  long	  been	  debated.	  In	  the	  seventies	  the	  American	  
Academy	  of	   Pediatrics	   recommended	   that	   genital	   surgery	   should	   be	   done	   at	   the	  
age	   of	   four	   for	   psychological	   reasons.	  During	   the	   last	   decades,	   based	   on	   indirect	  
proof,	   there	   has	   been	   a	   shift	   towards	   earlier	   treatment	   leading	   to	   a	   general	  
consensus	  that	  treatment	  should	  be	  given	  before	  the	  age	  of	  two.	  However,	  this	  has	  
yet	  to	  be	  proved	  in	  prospective	  studies	  where	  boys	  are	  randomized	  to	  surgery	  at	  
different	   ages	   and	   then	   followed	   through	   childhood	   and	   puberty	   to	   assess	   the	  
success	  of	  the	  treatment.	  	  
	  
The	  main	   objective	   of	   this	   thesis	   report	   is	   to	   present	   a	   prospective	   randomized	  




Incomplete	  descent	  of	  the	  testes	  is	  the	  most	  common	  congenital	  anomaly	  in	  boys,	  
but	   the	   defect	   can	   also	   be	   acquired	   during	   childhood.	   Most	   studies	   on	  
cryptorchidism	  are	  retrospective,	   lack	  standard	  definitions	  and	  nomenclature	   for	  
different	  forms	  of	  undescended	  testes	  and	  diagnose.	  In	  this	  thesis	  report	  we	  have	  
classified	   the	   boys	   examined	   according	   to	   their	   phenotype	   and	   used	   a	   clear	   and	  
consistent	  way	  of	  diagnosing	  the	  condition.	  	  	  
	  
Cryptorchidism	  can	  either	  be	  congenital	  or	  acquired.	  At	  examination	  the	  testis	  can	  
be	   classified	   as	   either	   uni-­‐	   or	   bilateral	   and	   palpable	   or	   non-­‐palpable	   in	   different	  
combinations.	   A	   retractile	   testis	   is	   a	   testis	   that	   temporarily	   resides	   above	   the	  
scrotum	  due	  to	  the	  cremaster	  muscle	  activity.	  	  
	  
	  
Fig.1. Shows the possible locations for an undescended testis. 
 
A	  palpable	  undescended	  testis	  can	  be	  found	  somewhere	  along	  the	  normal	  path	  for	  
descent	   in	   the	   inguinal	   canal,	   whereas	   an	   ectopic	   testis,	  on	   the	   other	   hand,	   has	  
deviated	  and	  can	  often	  be	  found	  at	  other	  locations	  in	  the	  inguinal	  and	  pubic	  regions	  
or	  even	   in	   the	  perineum	  on	  rare	  occasions.	  An	  ectopic	   testis	  can	  be	  diagnosed	  at	  
clinical	   examination	   but	   is	   commonly	   diagnosed	   during	   surgery.	   An	   iatrogenic	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retained	   testis	   is	   a	   testis	   that	   was	   previously	   located	   in	   the	   scrotum,	   but	   has	  
become	  retained	  after	   inguinal	   surgery	   such	  as	  hernia	   repair.	   	   In	   cases	  of	   a	  non-­‐
palpable	  unilateral	  testis	  the	  testis	  is	  either	  an	  intraabdominal	  testis	  or,	  if	  the	  testis	  










When	   determining	   the	   position	   of	   the	   testes	   in	   clinical	   practice	   it	   is	   often	   quite	  
obvious	   that	   a	   testis	   is	   non-­‐palpable	   or	   in	   a	   retained,	   position	   and	   cannot	   be	  
manipulated	  into	  the	  scrotum.	  	  
	  
Sometimes,	   however,	   it	   is	   difficult	   to	   assess	   whether	   the	   testis	   is	   in	   a	   retained	  
position	   or	   not,	   and	   the	   physicians’	   decision	   is	   then	   often	   based	   on	   his	   or	   her	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personal	   experience.	   	   The	   physician	   has	   to	   take	   into	   account	  where	   the	   testis	   is	  
located	  without	  manipulation,	   how	   far	   down	   the	   testis	   can	   be	  manipulated	   and	  
finally	   how	   long	   it	   will	   stay	   in	   its	   lowest	   position	   after	   the	   traction	   has	   been	  
released.	  The	  position	  during	  and	  after	  traction	  also	  depends	  on	  other	  factors	  such	  
as	  the	  experience	  of	  the	  physician,	  how	  much	  tension	  can	  be	  allowed,	  and	  how	  well	  
the	  boy	  cooperates.	  
	  
Consider	  the	  following	  example,	  which	  illustrates	  the	  difficulties	  and	  highlights	  the	  
need	   for	   standard	   definitions	   that	   will	   work	   in	   clinical	   practice:	   If	   a	   testis	   is	  
spontaneously	  located	  in	  the	  groin	  and	  can	  be	  pulled	  to	  the	  upper	  or	  lower	  part	  of	  
the	  scrotum	  and	  held	  there	  rather	  comfortably	  for	  the	  boy,	  but	  when	  the	  traction	  is	  
released	  the	  testis	  retracts	  back	  to	  its	  original	  position.	  Is	  this	  a	  retained	  testis	  or	  a	  
highly	   retractile	   one?	   Alternatively	   if	   the	   testis	   would	   stay	   in	   the	   scrotum	   for	   a	  
couple	  of	  seconds,	  would	  that	  change	  the	  decision?	  We	  can	  easily	  comprehend	  that	  
not	  all	  physicians	  will	  take	  the	  same	  decisions	  or	  in	  other	  words,	  some	  boys	  will	  be	  
referred	  to	  surgery	  and	  some	  boys	  will	  be	  discharged	  with	  no	  further	  follow-­‐up.	  	  
	  
The	   studies	   presented	   in	   this	   thesis	   report	   strictly	   use	   the	   following	   clinical	  
definition	  of	  a	  palpable	  undescended	  testis	  
The	  patient	   is	  examined	   in	  supine	  position	  with	   legs	  slightly	  bent.	  We	  determine	  
the	  position	  of	   the	  testis	  at	  one	  of	   three	   levels	  using	  the	  middle	  of	   the	  testis	  as	  a	  
reference	  point	  for	  each	  position:	  	  suprascrotal,	  (SS)	  upper	  portion	  of	  the	  scrotum	  
(US)	   or	   lower	   portion	   of	   scrotum	   (LS).	   If	   a	   testicle	   spontaneously	   assume	   a	  
suprascrotal	  position	  and	  cannot	  be	  pulled	  down	  into	  the	  scrotum,	  we	  categorize	  
this	  as	  an	  undescended	  testis.	  If	  a	  testicle	  in	  a	  suprascrotal	  position	  can	  be	  pulled	  
down	  into	  the	  scrotum,	  but	  will	  not	  remain	  there	  after	  about	  30	  seconds	  of	  traction	  
(to	  exhaust	  the	  cremasteric	  reflex),	  we	  define	  this	  as	  an	  undescended	  testis	  as	  well.	  
If	   the	   testis	   remains	   in	   upper	   or	   lower	   scrotum	   position	   for	   approximately	   10	  





Fig. 3. Figure shows the three positions assessed prior to and after traction that were 
used for diagnosing a palpable undescended testis. 
 
	  
1.3 Congenital	  cryptorchidism	  	  
1.3.1 Epidemiology	  
The	   prevalence	   of	   congenital	   cryptorchidism	   at	   birth	   is	   2	   –	   9	  %	   with	   apparent	  
geographical	  differences	  in	  the	  Nordic	  countries	  [1,	  2].	  Surprisingly	  in	  Denmark	  the	  
prevalence	  at	  birth	  is	  9	  %,	  whereas	  in	  Finland	  it	  is	  2	  –	  3	  %.	  Authors	  suggest	  that	  the	  
difference	   in	   prevalence	   between	   the	   countries	   may	   be	   attributed	   to	   genetic,	  
endocrine,	  environmental	  and	  lifestyle	  factors,	  as	  will	  be	  discussed	  later.	  Unilateral	  
cryptorchidism	   accounts	   for	   more	   than	   80	   %	   of	   all	   cases	   and	   bilateral	  






SS = suprascrotal	  
US = upper scrotum	  






1.3.2 Risk	  factors	  
Risk	   factors	   for	   cryptorchidism	   are	   low	   birth	  weight	   <2500	   g),	   prematurity	   and	  
small	   for	   gestational	   age	   and	   the	   condition	   is	   also	   associated	   with	   a	   higher	  
incidence	  of	  other	  congenital	  abnormalities	  of	  the	  external	  genitalia	  [4,	  5].	  	  
	  
1.3.3 Spontaneous	  descent	  
Due	  to	  spontaneous	  descent	  that	  occurs	  mainly	  within	  the	  first	  three	  months	  of	  life	  
the	  prevalence	  at	  the	  age	  of	  one	  year	  is	  1	  –	  2	  %.	  Spontaneous	  descent	  is	  more	  likely	  
to	  occur	  in	  preterm	  boys	  and	  infants	  with	  low	  birth	  weight.	  [3-­‐6].	  
	  
1.4 Acquired	  cryptorchidism	  	  
1.4.1 Epidemiology	  
The	  prevalence	  of	   cryptorchidism	  seems	   to	   increase	  with	  age,	   thus	   leading	   to	  an	  
increased	  number	  of	  orchidopexies	  with	  an	  accumulated	  prevalence	  of	  2	  –	  4	  %.	  	  In	  
one	  study	  the	  prevalence,	  without	  treatment,	  at	  ages	  6,	  9	  and	  13	  years	  were	  1.2	  %,	  
2.2%	  and	  1.2	  %	  respectively	  [7].	  	  On	  average	  orchidopexy	  is	  performed	  at	  the	  age	  
of	   four,	   in	  other	  words,	  at	  a	  much	  higher	  age	  than	   is	  currently	  recommended	  for	  
treatment.	   This	   clearly	   indicates	   that	   descended	   testes	   can	   ascend	   to	   a	   position	  
defined	  as	  cryptorchid.	  Highly	  retractile	  testes	  are	  suggested	  to	  be	  more	  prone	  to	  
ascend	  
	  
Some	   researchers	   define	   testes	   that	   at	   birth	   are	   cryptorchid	   followed	   by	  
spontaneous	   descent	   and	   then	   become	   cryptorchid	   again	   as	   recurrent	  
cryptorchidism,	   to	   be	   distinguished	   from	   true	  acquired	   cryptorchidism	   where	   the	  
testes	   are	   normal	   at	   birth.	   The	   John	   Radcliffe	   Hospital	   group	   found	   that	   a	  
considerable	  number	  of	   the	  testes	  that	  spontaneously	  descended	  were	  again	   in	  a	  
cryptorchid	   position	   when	   the	   boys	   were	   one	   year	   old.	   They	   came	   to	   the	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conclusion	  that	  this	  explains	  why	  so	  many	  orchidopexies	  were	  done	  compared	  to	  
the	  incidence	  of	  cryptorchidism	  found	  at	  the	  age	  of	  one	  [8-­‐10].	  	  
	  
1.4.2 Etiology	  
The	  etiology	  of	  acquired	  or	  recurrent	  cryptorchidism	  is	  unclear.	  Some	  researchers	  
have	   proposed	   that	   processus	   vaginalis	   open	   or	   as	   a	   fibrotic	   strand,	   can	   allow	  
ascensus	   to	   occur.	   Others	   have	   proposed	   that	   an	   overactive	   cremasteric	  muscle	  
(retractile	  testes)	  activity	  may	  be	  the	  cause,	  or	  that	  a	  relative	  cranial	  migration	  of	  
the	  testis	  may	  be	  the	  result	  of	  a	  discrepancy	  between	  the	  growth	  of	  the	  testicular	  
cord	  and	  the	  linear	  somatic	  growth	  of	  the	  patient	  [11-­‐13].	  	  
	  
1.4.3 Treatment	  
Several	  authors	  advocate	  a	  wait-­‐and-­‐see	  approach	  since	  a	  considerable	  number	  of	  
ascending	   testes	   (57	   -­‐	   78	  %)	  will	   descend	   spontaneously	   by	   puberty.	   However,	  
testes	   that	   do	   not	   descend	   require	   surgery	   and	   are	   often	   smaller	   than	   the	  
contralateral	   testis.	   	   [10,	   14-­‐17].	   Histopathological	   studies	   on	   acquired	   forms	   of	  
cryptorchidism	   show	   that	   they	   undergo	   germ	   cell	   deterioration,	   in	   the	   same	  
manner	  as	  in	  congenital	  undescended	  testes	  [18,	  19].	  	  
	  
1.4.4 Conclusion	  
Testes	  in	  acquired	  cryptorchidism	  will	  be	  exposed	  to	  the	  same	  adverse	  conditions	  
in	   the	  groin	  as	   true	  cryptorchid	   testes	  and	  consequently	   some	  of	   them	  will	  have	  
impaired	   growth	   and	   spermatogenesis.	   No	   prognostic	   factors	   in	   childhood	   have	  
been	  identified	  by	  which	  we	  could	  assess	  whether	  a	  testis	  will	  descend	  by	  puberty	  
or	   not.	   Based	   on	   these	   data	   it	   has	   been	   recommended	   to	   consider	   surgical	  





1.5 Retractile	  testes	  
1.5.1 Epidemiology	  
In	  clinical	  practice	  retractile	  testes	  are	  often	  regarded	  as	  normal.	  The	  parents	  are	  
often	   assured	   that	   the	   condition	   will	   correct	   itself	   and	   thus	   their	   boys	   are	  
frequently	   discarded	   from	   further	   follow-­‐ups.	   	   Retractility	   is	   attributed	   to	   the	  
activity	  of	  the	  cremaster	  muscle	  and	  is	  absent	  during	  the	  first	  months	  of	  life.	  As	  in	  
acquired	  forms	  of	  cryptorchidism	  a	  major	  part	  of	  these	  testes	  (77	  %)	  will	  descend	  
spontaneously	   into	   the	   scrotum	   by	   puberty	   [21].	   Retractile	   testes	   are	   most	  
common	  in	  the	  pre-­‐school	  period	  with	  a	  peak	  period	  around	  5	  -­‐	  8	  years	  of	  age.	  The	  
peak	   period	   coincides	   with	   the	   period	   when	   the	   prevalence	   of	   acquired	  
cryptorchidism	   is	   high,	   thus	   suggesting	   that	   retractile	   testes	   are	   often	  
misdiagnosed	  as	  truly	  undescended	  testes	  [22].	  	  
	  
Furthermore,	   histological	   studies	   show	   that	   retractile	   testes	   exhibit	   the	   same	  
adverse	  histological	  changes	  as	  cryptorchid	  testes	  and	  may	  therefore	  be	  a	  cause	  of	  
subfertility	  with	  abnormal	  spermiograms.	  Retractility	  was	  found	  more	  frequently	  
in	  infertile	  men	  treated	  for	  undescended	  testes	  in	  childhood	  than	  in	  the	  population	  
in	  general:	  30	  versus	  12	  %	  [23-­‐26].	  A	  recent	  study	  of	  retractile	  testes	  in	  boys	  has	  
shown	  that	  the	  testicular	  volume	  was	  lower	  than	  in	  boys	  with	  scrotal	  testes	  [27].	  
	  
1.5.2 Definition	  
The	  definition	  used	  in	  our	  studies	  is	  discussed	  in	  the	  section	  on	  diagnosis.	  Attempts	  
have	   been	  made	   to	   define	   a	   retractile	   testis	   in	   adults.	   In	   one	   study	   the	   authors	  
defined	   a	   retractile	   testis	   as	   one	   that	   at	   least	   once	   a	  week	   ascends	   to	   a	   position	  
above	   the	   scrotum	   [24].	   However,	   in	   our	   point	   of	   view	   it	   would	   be	   almost	  
impossible	   to	   practise	   this	   definition	   on	   boys	   since	   there	   is	   no	   objective	  way	   of	  




Consequently	   there	   are	   highly	   retractile	   testes	   that	   almost	   never	   stay	   in	   the	  
scrotum	  during	  an	  ill-­‐defined	  period	  and	  there	  are	  testes	  that	  remain	  in	  place	  most	  
of	   the	   time.	   This	   results	   in	   a	   clinical	   dilemma:	   	  which	   boys	   should	  we	   treat	   and	  
which	  boys	  should	  be	   followed	  or	  discharged	  from	  further	   follow-­‐up?	  The	  highly	  
retractile	  testes	  that	  occur	  in	  periods	  with	  high	  cremaster	  muscle	  activity	  may	  very	  
well	  be	  what	  many	  physicians	  would	  regard	  as	  cases	  of	  acquired	  cryptorchidism.	  	  
	  
1.5.3 Conclusion	  
So	   in	   summary	   retractile	   testes,	   congenital	   and	   acquired	   forms	   of	   undescended	  
testes	   can	  be	  difficult	   to	  distinguish	   from	  each	  other	  and	   is	   therefore	   sometimes	  
diagnosed	   incorrectly.	   In	   addition,	   all	   forms	   are	   at	   risk	   for	   impaired	  
spermatogenesis.	  Some	  testes	  in	  acquired	  cryptorchidism	  will	  descend	  by	  puberty	  
however	   no	   prognostic	   factors	   in	   childhood	   have	   been	   identified	   by	   which	   we	  
could	  assess	  whether	  a	  testis	  will	  descend	  or	  not.	  
	  
Numerous	   studies	   on	   these	   different	   forms	   of	   cryptorchidism	   are	   retrospective,	  
which	   makes	   it	   very	   difficult	   to	   assess	   and	   compare	   the	   results.	   The	   lack	   of	  
standard	  definitions	   results	   in	   a	  mix	   of	   different	   forms	  of	   undescended	   testes	   in	  
patient	  materials,	  which	   emphasizes	   the	   need	   for	   prospective	   studies	  with	   clear	  
definitions	  and	  nomenclature.	  	  
	  
	  
1.6 Normal	  testicular	  descent	  
Testicular	  descent	   is	   a	   complex	  process	   that	  only	  occurs	   in	  mammals.	  Most	  data	  
are	   collected	   from	   animal	   studies	   and	   therefore	   not	   always	   easy	   to	   translate	   to	  
conditions	  in	  man.	  	  However,	  it	  is	  widely	  accepted	  that	  testicular	  descent	  occurs	  in	  
two	   separate	   phases:	   firstly	   the	   non-­‐androgen	   dependent	   transabdominal	   phase	  
and	   secondly	   the	   androgen-­‐dependent	   inguinoscrotal	   phase,	   where	   the	   second	  




1.6.1 Transabdominal	  phase,	  gestational	  week	  6	  to	  15	  
When	  the	  embryo	  is	  six	  to	  eight	  weeks	  the	  testes	  are	  formed	  from	  undifferentiated	  
gonads,	  close	  to	  the	  kidneys.	  The	  testes	  secrete	  AMH	  (anti	  müllerian-­‐hormone)	  and	  
testosterone.	  	  AMH	  causes	  regression	  of	  the	  Mullerian	  ducts,	  preventing	  the	  boy	  to	  
develop	  internal	  female	  genitalia	  (uterus	  and	  fallopian	  tubes).	  Testosterone	  causes	  
regression	  of	  the	  cranial	  suspensatory	  ligament	  (CSL),	  a	  ligament	  that	  anchors	  the	  
testes	  close	  to	  the	  kidneys.	  Simultaneously	  the	  Leydig	  cells	  produce	  INSL3	  (insulin-­‐
like	   hormone	   peptide)	   that	   causes	   enlargement	   and	   swelling	   of	   the	   caudal	  
ligament,	   the	   gubernaculum.	   The	   masculinisation	   process	   also	   depends	   on	   a	  
functioning	  receptor	  for	  INSL3,	  LGR8	  [30].	  These	  events	  lead	  to	  attachment	  of	  the	  
testes	  close	  to	  the	  internal	  ring,	  preventing	  the	  testes	  to	  ascend	  to	  a	  position	  high	  in	  
the	  abdomen	  as	  ovaries	  do	  with	  the	  enlargement	  of	  the	  embryo	  [31].	  	  
	  
1.6.2 Inguinoscrotal	  phase,	  gestational	  week	  25	  to	  35	  
During	   the	   inguinoscrotal	   phase	   the	   gubernaculum	   elongates	   and	  migrates	  with	  
the	   testis	   from	   the	   inguinal	   region	   through	   the	   inguinal	   canal	   into	   the	   scrotum.	  
Androgens	   regulate	   the	   migration	   by	   acting	   through	   the	   calcitonin-­‐gene-­‐related	  
peptide	   (CGRP),	   which	   is	   a	   neurotransmittor	   that	   acts	   chemotactically	   on	   the	  
gubernaculum.	  CGRP	  is	  released	  by	  the	  genitofemoral	  nerve	  (GFN),	  and	  considered	  
to	  be	  a	  key	  regulator	  in	  the	  second	  phase	  of	  testicular	  descent.	  Animal	  studies	  have	  
shown	  that	  transection	  of	  the	  genitofemoral	  nerve	  results	  in	  cryptorchidism	  [29].	  	  
	  
The	  migration	  of	  the	  testis	  through	  the	  inguinal	  canal	  is	  also	  considered	  to	  depend	  
on	   abdominal	   pressure.	   In	   vitro	   studies	   show	   that	   CGRP	   may	   obliterate	   the	  
processus	   vaginalis	   after	   completed	   descent	   [28].	   If	   this	   is	   of	   importance	   in	   the	  
pathogenesis	  of	  undescended	  testis	  is	  unclear,	  but	  it	  is	  interesting	  to	  note	  that	  boys	  
operated	  on	   for	  undescended	   testes	  often	  have	  a	  patent	  processus	  vaginalis.	  The	  




1.7 Pathogenesis	  	  
The	   pathogenesis	   for	   cryptorchidism	   is	   considered	   to	   be	   multifactorial.	   Many	  
etiologies	  have	  been	  suggested	  for	  congenital	  cryptorchidism	  but	  it	  occurs	  mostly	  
as	   an	   isolated	   disorder	  with	   no	   obvious	   single	   cause	   but	   can	   be	   associated	  with	  
genetic,	   endocrine	   and	   somatic	   disorders.	   Several	   environmental	   and	   maternal	  
factors	  have	  also	  been	  proposed	  to	  play	  a	  role.	  	  
	  
1.7.1 Genetics	  
In	   animal	   studies	   on	   knockout	   XY	   mice	   for	   the	   INSL-­‐3	   gene	   are	   found	   to	   be	  
cryptorchid	   with	   impaired	   spermatogenesis	   [34,	   35].	   In	   man	   mutations	   of	   the	  
INSL3-­‐gene	  and	  its	  receptor	  LGR8-­‐gene	  rarely	  cause	  cryptorchidism	  	  -­‐	  only	  a	  few	  
percent	  of	  all	  cases.	  Epidemiological	  studies	  on	  familial	  cryptorchidism	  show	  that	  
brothers	  of	  cryptorchid	  boys	  have	  a	  6	  %	  risk	  and	  fathers	  about	  4	  %	  compared	  to	  
the	  population.	  	  In	  bilateral	  cases	  even	  a	  higher	  risk	  of	  recurrence	  is	  revealed	  [36,	  
37].	   One	   explanation	   for	   the	   low	   frequency	   of	  mutations	   in	   INSL-­‐3	   gene	   and	   its	  
receptor	   may	   be	   attributed	   to	   the	   fact	   that	   the	   first	   phase	   of	   testicular	   descent	  
seldom	  fails	  or	  that	  many	  other	  genes	  are	  involved,	  which	  are	  not	  yet	  identified.	  	  
	  
1.7.2 Clinical	  conditions	  and	  syndromes	  	  
Persistent	   müllerian	   duct	   syndrome	   is	   a	   rare	   condition	   where	   a	   boy	   who	   has	  
bilateral	   cryptorchidism	   also	   has	   internal	   female	   genitalia.	   This	   syndrome	   is	  
caused	  by	  a	  mutation	  in	  the	  AMH	  gene	  or	  its	  receptor	  for	  anti-­‐müllerian	  hormone	  
(AMH)	  that	  prevents	  the	  regression	  of	  the	  müllerian	  ducts	  resulting	  in	  a	  uterus	  and	  
fallopian	  tubes	  in	  an	  otherwise	  normal	  boy.	  	  
	  
Abdominal	  pressure	  is	  considered	  to	  be	  important	  in	  the	  second	  phase	  of	  descent,	  
interestingly	   infants	  with	   low	   abdominal	   pressure	   in	   conditions	   like	   gastrochisis	  
have	   a	   higher	   incidence	   of	   undescended	   testes	   [38].	   Syndromes	   with	   muscular	  
hypotonia	  such	  as	  Down,	  prune	  belly	  and	  Prader	  Villi	  also	  have	  a	  higher	  incidence	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of	   cryptorchidism.	   The	   same	   can	   be	   said	   about	   patients	  with	   spina	   bifida	   in	   the	  
caudal	   segment,	   suggesting	   that	   the	   genitofemoral	   nerve	   play	   a	   role,	   not	   only	   in	  
animal	  models	   but	   also	   in	  man.	   Cryptorchidism	   is	   also	   associated	  with	   a	   higher	  
incidence	  of	  hypospadias	  and	  ambiguous	  genitalia	  [39].	  	  
	  
1.7.3 Androgen	  disorders	  
The	   second	   phase	   of	   normal	   testicular	   descent	   is	   androgen	   dependent	   and	  
therefore	   various	   androgen	   deficiencies	   have	   a	   higher	   incidence	   of	   congenital	  
cryptorchidism.	   The	   mechanisms	   include	   inadequate	   production	   or	   action	   of	  
androgens	   as	   in	   hypogonadotropic	   hypogonadism	   and	   mutations	   or	   a	   deficient	  
action	  on	  the	  androgen	  receptor.	  	  
	  	  
1.7.4 Environmental	  and	  maternal	  factors	  
Estrogens,	   pesticides	   and	   phthalates	   have	   all	   been	   proposed	   to	   play	   a	   role	   in	  
cryptorchidism.	   	   For	   instance,	   pesticides	   in	   breast	   milk	   are	   associated	   with	  
congenital	   cryptorchidism.	   Some	   researchers	   suggest	   that	   estrogens	   in	   the	  
environment	   may	   cause	   a	   disrupted	   ratio	   between	   androgens	   and	   estrogens	  
leading	   to	   an	   inadequate	  maturation	   of	   Sertoli	   and	   Leydig	   cells.	   However,	   these	  
studies	   are	   not	   conclusive	   and	   show	   contradictive	   results	   [32,	   40-­‐42].	   Maternal	  
factors	   such	   as	   smoking	   and	   alcohol	   consumption	   during	   pregnancy	   have	   been	  
studied	  and	  considered	  to	  cause	  bilateral	  cryptorchidism,	  but	  the	  mechanisms	  for	  
these	   associations	   are	   not	   known.	   It	   has	   been	   speculated	   that	   the	   accumulative	  
effects	   of	   many	   different	   exposures	   may	   have	   adverse	   consequences	   especially	  








1.8 	  	  Testicular	  cancer	  
1.8.1 Cryptorchidism	  and	  malignancy	  	  
Decades	  ago	  it	  was	  assumed	  that	  the	  relative	  risk	  of	  testicular	  cancer	  was	  40	  -­‐	  50	  
times	   higher	   in	   men	   treated	   for	   cryptorchidism	   than	   in	   the	   general	   male	  
population.	  Today,	  based	  on	  cohort	  studies,	  the	  relative	  risk	  is	  considered	  to	  be	  4-­‐8	  
fold	   times	   higher.	   In	   bilateral	   undescended	   testes	   the	   relative	   risk	   to	   develop	  
malignancy	   in	  each	  testis	   is	  slightly	  higher	  than	   in	  unilateral	  cryptorchidism	  [46-­‐
49].	  	  
	  
Another	   issue	   discussed	   is	   whether	   the	   contralateral	   testis	   in	   unilateral	  
cryptorchidism	   is	   at	   higher	   risk	   for	   developing	   future	   malignancy.	   The	   results	  
obtained	   are	   somewhat	   contradictory,	   but	   generally	   there	   seems	   to	   be	   a	   slightly	  
increased	  risk	  [46,	  50,	  51].	  	  
	  
In	  Denmark	  the	  prevalence	  of	  cryptorchidism	  at	  birth	  is	  9	  %,	  higher	  than	  in	  other	  
Nordic	   countries,	   interestingly	  men	   in	   Denmark	   also	   have	   a	   higher	   incidence	   of	  
testicular	   cancer	   and	   impaired	   semen	   quality.	   The	   cause	   of	   the	   geographical	  
difference	   is	   unclear	   but	   may	   be	   attributed	   to	   genetic,	   maternal,	   lifestyle	   or	  
environmental	  factors	  [2,	  41,	  45,	  52].	  	  
	  
Men	  with	   untreated	   cryptorchidism	   is	   at	   higher	   risk	   for	   developing	   seminomas,	  
whereas	  treated	  men	  are	  more	  likely	  to	  develop	  nonseminomatous	  tumors	  [53].	  	  
	  
Removal	  of	  the	  testis	  is	  recommended	  in	  adult	  men	  with	  unilateral	  cryptorchidism	  
since	   studies	   show	   highly	   impaired	   spermatogenesis	   at	   this	   age	   and	   also	   a	  






1.8.2 Age	  at	  treatment	  and	  malignancy	  
There	   are	   no	   published	   studies	   that	   conclude	   that	   orchidopexy	   in	   early	   infancy	  
reduces	   the	   risk	   of	  malignancy.	   Testicular	   cancer	   usually	   occurs	   in	  men	   over	   30	  
years,	   so	   consequently	   the	   current	   cohorts	   on	   malignancy	   are	   based	   on	   how	  
cryptorchidism	   was	   treated	   decades	   ago	   -­‐	   that	   is	   at	   a	   much	   higher	   age	   than	  
recommended	  today.	  	  
	  
Some	  studies	  have	  not	  been	  able	  to	  correlate	  age	  at	  surgery	  with	  testicular	  cancer	  
[55].	  On	  the	  other	  hand,	  a	  Swedish	  study	  shows	  that	  the	  relative	  risk	  of	  developing	  
testicular	   cancer	   is	   2.23	   times	   higher	   if	   treatment	   is	   given	   before	   the	   age	   of	  
thirteen,	   compared	   to	   later	   treatment	  where	   the	   relative	   risk	   is	   5.4	   	   [56].	   These	  
figures	  are	  also	  confirmed	  in	  other	  studies	  [57].	  	  
	  
1.8.3 Carcinoma	  in	  situ	  
Carcinoma	   in	   situ	   or	   CIS	   is	   a	   precursor	   of	   testicular	  malignancies.	   Authors	   have	  
hypothesized	   that	   CIS	   originates	   during	   fetal	   development.	   It	   results	   in	   a	   defect	  
transformation	   to	   spermatogonia	   leading	   to	   pluripotent	   stem	   cells	   that	   are	   at	  
higher	  risk	  for	  malignant	  transformation	  [58].	  
	  
The	  prevalence	  of	  CIS	  in	  men	  with	  a	  history	  of	  cryptorchidism	  is	  2	  -­‐	  4	  %	  and	  less	  
than	   1	   %	   in	   the	   general	   population,	   which	   is	   similar	   to	   the	   lifetime	   risk	   of	  
developing	  testicular	  cancer	  with	  preceding	  carcinoma	   in	  situ	  [46,	  47,	  50,	  59].	   In	  
men	  with	   testicular	   cancer	   a	   biopsy	   on	   the	   contralateral	   testis	   showed	   that	   the	  
prevalence	  of	  CIS	  was	  5	  %	  and	  the	  risk	  of	  progress	  to	  invasive	  malignancy	  was	  50	  
%	  in	  5	  years	  [60-­‐62].	  
	  
In	  a	  cohort	  study	  Swerdlow	  et	  al.	  conclude	  that	  the	  biopsy	  itself	  is	  a	  risk	  factor	  for	  
malignancy	  in	  the	  biopsied	  testis.	  However,	  these	  results	  are	  widely	  disputed	  and	  
no	  relation	  has	  been	  proven	   in	  other	  cohorts	   [50,	  61].	  Microcalcifications	  and	   its	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relevance	   for	   future	  malignancy	  have	  been	  discussed	   and	   there	   is	   no	   agreement	  
how	  these	  should	  be	  followed	  clinically	  and	  recommendations	  vary	  [63,	  64].	  Some	  
studies	   show	   a	   correlation	   between	   testicular	   microcalcifications	   (TM)	   and	  
carcinoma	   in	   situ	   [65,	   66],	   but	   other	   researchers	   conclude	   that	   TM	   alone	   is	   not	  
premalignant	  in	  itself	  [67].	  	  
	  
1.8.4 Conclusion	  
Cryptorchid	  boys	  are	  at	  higher	  risk	  for	  developing	  carcinoma	  in	  situ	  and	  testicular	  
cancer	   as	   adults.	   Published	   data	   reflects	   the	   time	   when	   almost	   no	   surgical	  
treatment	   was	   undertaken	   before	   the	   age	   of	   two.	   Orchidopexy	   before	   puberty	  
clearly	   reduces	   the	   above-­‐mentioned	   risks,	   but	   it	   remains	   to	   be	   proven	   that	  
orchidopexy	  before	  the	  age	  of	  one	  reduces	  the	  risk	  even	  further.	  	  
	  
	  
1.9 Hormonal	  treatment	  
During	  the	  last	  decade	  hormonal	  treatment	  for	  cryptorchidism	  has	  lost	  popularity	  
in	  Europe	  due	  to	  a	  low	  efficacy	  rate	  and	  a	  highly	  potential	  risk	  for	  adverse	  effect	  on	  
the	  testis	  itself.	  Therefore	  this	  mode	  of	  treatment	  will	  only	  be	  discussed	  briefly	  in	  
this	  report.	  	  
	  
1.9.1 Modes	  of	  treatment	  
Treatment	  options	   include	   the	  use	  of	  human	  chorionic	  gonadotrophin	   (hCG)	  and	  
gonadotrophin-­‐releasing	   hormone	   (GnRH).	   These	   hormones	   have	   been	   used	  
separately	   or	   in	   combination,	   and	   also	   prior	   to	   or	   after	   surgical	   treatment.	   Both	  
hCG	   and	   GnRH	   (through	   LH	   release)	   stimulate	   the	   Leydig	   cells	   to	   produce	  
testosterone.	  
	  
Some	   researchers	   suggest	   that	   postoperative	   hormonal	   treatment	   has	   beneficial	  
effects	  on	  sperm	  counts	  in	  adulthood	  [68,	  69].	  In	  one	  study	  boys	  were	  randomized	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either	  to	  surgery	  only	  or	  to	  GnRH	  treatment	  prior	  to	  orchidopexy.	  The	  results	  show	  
that	   treatment	  prior	   to	  surgery	   improves	  the	  number	  of	  dark	  spermatogonia	  per	  
tubule.	  [70].	  These	  findings	  were	  confirmed	  by	  Hadziselimovic	  et	  al.	  who	  showed	  
in	   a	   study	   that	   hormonal	   treatment	   prior	   to	   surgery	   induces	   the	   maturation	  
process	   to	   dark	   spermatogonia.	   Also,	   the	   results	   could	   be	   directly	   correlated	   to	  




Four	   different	  modes	   of	   hormonal	   treatment	  were	   evaluated	   in	   a	   study	  with	   an	  
overall	  success	  rate	  of	  about	  20	  %.	  The	  recurrence	  rate	  six	  months	  after	  treatment	  
was	  23	  %,	  which	  confirms	   the	  results	   from	  several	  meta-­‐analyzes,	   showing	  even	  
lower	  efficacy	  rates	   if	   retractile	   testes	  were	  excluded.	  The	  results	  were	   the	  same	  
for	  all	  the	  different	  modes	  of	  treatment	  	  [72-­‐75].	  
	  
1.9.3 Adverse	  effects	  
HCG	  treatment	  has	  proved	  to	  have	  adverse	  effects	  on	  the	  testis	  itself,	  causing	  germ	  
cell	   apoptosis	   and	   lesser	   testicular	   volume	   in	   adulthood	   [76-­‐79].	   In	   addition	  
multiple	  intramuscular	  injections	  treatment	  with	  hCG	  has	  clinical	  side	  effects	  such	  
as	   acute	   inflammatory	   reaction	   of	   the	   testes,	   enlargement	   of	   the	   genitalia,	   pubic	  
hair	  growth	  and	  possible	  aggressive	  behaviour	  of	  the	  child.	  Treatment	  with	  GnRH	  
has	  not	  presented	  any	  clinical	  side	  effects.	  	  
	  [20].	  	  
	  
1.9.4 Conclusion	  
Due	  to	   the	   low	  efficacy	  rate	  and	  the	  adverse	  effects	  after	  hormonal	   treatment	  on	  
the	  testis,	  the	  Nordic	  consensus	  report	  recommends	  surgery	  as	  the	  primary	  choice	  
of	  therapy	  for	  undescended	  testes.	  Hormonal	  therapy	  may	  be	  considered	  in	  cases	  
where	   surgery	   is	   not	   an	   option.	   At	   present,	   no	   conclusive	   evidence	   supports	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hormonal	   treatment	   before	   or	   after	   surgery.	   More	   studies	   on	   this	   subject	   are	  
required	  [20].	  	  
	  
	  
1.10 Surgical	  treatment	  
1.10.1 Success	  rates	  	  
The	  short-­‐time	  definition	  of	  success	  after	  orchidopexy	   is	  a	  scrotal	  position	  of	   the	  
testis	  without	  atrophy	  or	  recurrence,	  whereas	  the	  long-­‐term	  definition	  of	  success	  
would	  be	  preserved	  functionality.	  A	  successful	  orchidopexy	  is	  not	  a	  guarantee	  for	  
optimal	  functionality,	  and	  in	  some	  cases	  a	  testis	   is	  fixated	  in	  a	  position	  above	  the	  
scrotum	  just	  to	  preserve	  hormonal	  functionality	  and	  assure	  palpability.	  	  
	  
The	  success	  rate	  varies	  depending	  on	  the	  location	  of	  the	  testes,	  experience	  of	  the	  
surgeon,	   age	  of	   the	  patient	   at	   time	  of	   surgery	   and	  other	   factors	   as	  well.	  A	  meta-­‐
analysis	   by	  Docimo	   et	   al.	   of	   64	   studies	   shows	   that	   the	   success	   rate	   for	   palpable	  
inguinal	  testes	  is	  approximately	  90	  %	  and	  for	  abdominal	  testes	  74	  %.	  Success	  by	  
procedure	  was	  approximately	  90	  %	  for	  an	  inguinal	  approach,	  and	  70	  -­‐	  80	  %	  for	  the	  
different	   techniques	   used	   for	   the	   intraabdominal	   testes.	   During	   the	   last	   decade	  
success	  rates	  have	  improved	  with	  new	  surgical	  approaches	  and	  more	  experience	  of	  
different	  techniques	  [53,	  80,	  81].	  
	  
Management	   of	   the	   palpable	   and	   the	   non-­‐palpable	   testes	   and	   a	   relatively	   short	  
description	  of	   the	  different	  surgical	  options	  and	   techniques	  are	  presented	   in	   this	  
report.	  	  For	  more	  details	  see	  review	  by	  Thorup	  et	  al.	  [82].	  	  
	  
1.10.2 Management	  of	  the	  palpable	  testis	  
Surgical	   management	   of	   unilateral	   or	   bilateral	   palpable	   testes	   aims	   to	   create	   a	  
Darto´s	  pouch	  in	  the	  scrotum,	  which	  can	  be	  achieved	  by	  a	  single	  scrotal	  technique	  
or	  a	  two-­‐incision	  technique.	  The	  single	  incision	  technique	  or	  transscrotal	  approach	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is	  often	  used	   for	  more	  distal	   testes	  as	  described	  by	  Bianchi,	  and	   is	  preferable	   for	  
surgeons	  familiar	  with	  the	  technique	  [83].	  The	  two-­‐incision	  technique	  involves	  an	  
incision	  in	  the	  groin	  and	  one	  in	  the	  scrotum	  to	  create	  the	  pouch.	  In	  this	  prospective	  
study	  the	  latter	  has	  been	  the	  method	  of	  choice	  for	  all	  palpable	  testes.	  The	  technique	  
is	  described	  in	  more	  detail	  in	  the	  section	  on	  methods.	  	  
	  
1.10.3 Management	  of	  the	  non-­‐palpable	  testis	  
According	   to	   present	   recommendations	   orchidopexy	   should	   be	   performed	  
between	   six	   and	   twelve	   months	   of	   age	   by	   an	   experienced	   pediatric	   surgeon	   or	  
urologist	   and	   by	   a	   pediatric	   anesthesiologist.	   Initial	   diagnostic	   laparoscopy	   has	   a	  
high	   accuracy	   rate.	   It	   is	   widely	   used	   among	   surgeons	   as	   the	   initial	   step	   in	   the	  
management	   of	   the	   non-­‐palpable	   testis	   and	   provides	   information	   regarding	   the	  
next	   surgical	   step.	   	   Imaging	   techniques	   such	   as	   ultrasonography,	   computed	  
tomography	   (CT)	   or	   magnetic	   resonance	   imaging	   (MRI)	   are	   not	   recommended	  
routinely	   since	   they	   are	   less	   sensitive	   than	   an	   experienced	   physician	   and	   not	  
always	  easily	  accessible	  in	  clinical	  practice	  [84].	  For	  young	  boys	  the	  use	  of	  MRI	  and	  
CT	   is	  not	   justified	  since	   these	  methods	  generally	  require	  anesthesia.	  However,	   in	  
some	  situations	  ultrasonography	  may	  be	  of	  diagnostic	  value,	   for	  example	  when	  a	  
boy	  is	  difficult	  to	  palpate	  due	  to	  obesity	  or	  a	  lack	  of	  cooperation.	  	  
	  
Findings	  at	  laparoscopy	  and	  surgical	  management	  	  
In	  boys	  with	  non-­‐palpable	  testes	  laparoscopy	  revealed	  an	  intraabdominal	  testis	  in	  
36	  %	  of	  the	  cases,	  blind	  ending	  vessels	  in	  44	  %	  and	  an	  inguinal	  testis	  or	  remnant	  in	  
20	  %	  of	  the	  cases.	  The	  next	  surgical	  step	  is	  based	  on	  the	  intraoperative	  findings	  at	  
laparoscopy	  [85].	  	  
	  
Blind	  ending	  vas	  deferens	  and	  vessels:	   In	  unilateral	  cases	  no	  further	  exploration	  or	  
evaluation	   is	   needed	  whereas	   in	   bilateral	   cases	   the	   boy	   should	   be	   referred	   to	   a	  
pediatric	  endocrinology	  unit	  for	  evaluation	  and	  future	  hormonal	  substitution.	  	  
	  19	  
	  
Vas	   deferens	   and	   vessels	   exiting	   a	   closed	   or	   open	   internal	   ring:	   In	   these	   cases	   an	  
inguinal	  exploration	  should	   follow	  after	   laparoscopy.	   If	   the	   internal	  ring	  is	  closed	  
there	  is	  almost	  certainly	  a	  remnant	  or	  nubbin	  in	  the	  inguinal	  canal.	  This	  remnant	  
should	  be	  extirpated	  since	  it	  has	  been	  shown	  that	  viable	  germ	  cell	  tissue	  exists	  in	  a	  
few	   percent	   of	   all	   remnants	   with	   a	   risk	   of	   progressing	   to	   a	   future	   malignant	  
transformation.	  However,	  this	  has	  not	  been	  proven	  in	  follow-­‐up	  studies.	  An	  open	  
internal	  ring	  is	  a	  clear	  indication	  that	  there	  is	  a	  viable	  testis	  in	  the	  canal	  [86,	  87].	  
Fig. 4. On the left the vas deferens and spermatic vessels are entering a closed 
internal ring in a boy with a viable testis in the inguinal canal. On the right the vessels 
are ending blindly in a monorchid boy	  
	  
Unilateral	  intraabdominal	  testis:	  The	  testis	  can	  be	  located	  very	  close	  to	  the	  internal	  
ring	  it	  is	  sometimes	  referred	  to	  as	  a	  peeping	  testis	  or	  a	  low	  abdominal	  testis,	  or	  if	  it	  
is	  located	  higher	  in	  the	  abdomen	  a	  high	  intraabdominal	  testis.	  	  
	  
A	   testis	   close	   to	   the	   internal	   ring	   or	   even	   a	   higher	   located	   testis	   can	   often	   be	  
brought	   down	   to	   scrotum	   by	   a	   high	   inguinal	   incision	   followed	   by	   an	   extensive	  




If	   the	   surgeon	   during	   laparoscopy	   finds	   that	   sufficient	   length	   for	   a	   scrotal	  
orchidopexy	   cannot	   be	   achieved	   a	   Fowler-­‐Stephens	   procedure	   is	   sometimes	  
chosen,	  meaning	  the	  spermatic	  vessels	  need	  to	  be	  divided.	  The	  blood	  circulation	  to	  
the	   testis	   will	   then	   depend	   on	   collateral	   circulation	   from	   the	   vas	   deferens,	  
gubernaculum	  and	  cremasteric	  muscle	  fibres.	  A	  Fowler-­‐Stephens	  procedure	  can	  be	  
done	  either	  openly	  or	  laparoscopically	  in	  a	  single-­‐stage	  or	  a	  two-­‐stage	  procedure.	  
The	  two-­‐stage	  procedure	  means	  that	   firstly	  the	  testis	   is	   left	   in	  an	   intraabdominal	  
position	  without	  tension	  in	  order	  to	  optimize	  the	  development	  of	  collateral	  blood	  
circulation.	  The	  second	  stage	  or	  the	  actual	  orchidopexy	  should	  be	  done	  at	  least	  six	  
months	   after	   the	   ligation	   of	   the	   vessels.	   The	   single-­‐stage	   procedure	   means	   that	  
vessels	   are	   divided	   and	   an	   orchidopexy	   is	   performed	   in	   the	   same	   surgical	  
procedure.	  	  
	  
It	  has	  been	  shown	  by	  Thorup	  et	  al.	  that	  germ	  cells	  may	  survive	  the	  ligation	  of	  the	  
vessels,	  whereas	  the	  number	  of	  spermatogonia	  decreases,	  which	  is	  also	  confirmed	  
in	   an	   animal	   model.	   Therefore	   testicular	   atrophy	   and/or	   impaired	  
spermatogenesis	  are	  potential	  complications	  of	  this	  technique	  [89,	  90].	  
	  
Consequently,	   the	   challenge	   for	   the	   surgeon	   during	   laparoscopy	   is	   to	   assess	  
whether	   or	   not	   it	   is	   possible	   to	   bring	   the	   testis	   down	   to	   the	   scrotum	   without	  
dividing	   the	  vessels,	   thereby	  reducing	   the	   risk	  of	   impaired	  spermatogenesis.	  The	  
decision	  must	   be	   based	   on	   the	   surgeon’s	   personal	   experience	   since	   no	   objective	  
methods	  have	  been	  described	  and	  randomized	  prospective	  studies	  are	  lacking.	  	  
	  
If	  inguinal	  exploration	  is	  chosen	  after	  laparoscopy	  and	  sufficient	  length	  cannot	  be	  
achieved	  and	  a	  subsequent	  Fowler-­‐Stephens	  orchidopexy	  is	  performed,	  this	  would	  
in	  our	  opinion	  not	  be	  optimal	  since	  the	  dissection	  in	  the	  groin	  itself	  most	  likely	  will	  
compromise	  the	  collateral	  circulation	  to	  develop	  and	  therefore	  the	  risk	  for	  atrophy	  




In	  case	  of	  a	  solitary	  intraabdominal	  testis	  in	  monorchid	  boys	  most	  surgeons	  would	  
probably	  not	  perform	  a	  Fowler-­‐Stephens	  orchidopexy	  due	   to	   the	   risk	  of	   atrophy	  
and	   subsequent	   androgen	   substitution	   throughout	   life.	   The	   general	   consensus	   is	  
that	   the	   testis	   should	   be	   placed	   in	   a	   palpable	   position	   in	   the	   lowest	   possible	  
location	  without	  tension.	  	  
	  
Orchidectomi	  can	  be	  considered	  in	  cases	  of	  uncorrected	  unilateral	  cryptorchidism	  
in	  men	  with	  a	  normally	  descended	  testis	  and	  a	  contralateral	  high	  abdominal	  testis.	  
The	  reason	  is	  a	  severely	  compromised	  fertility	  and	  higher	  risk	  of	  testicular	  cancer	  
(as	  discussed	  later	  in	  the	  section	  on	  testicular	  cancer)	  in	  the	  retained	  testis.	  	  
	  
Bilateral	  intraabdominal	  testes:	  The	  management	  of	  bilateral	  high	   intraabdominal	  
testes	   probably	   varies	   among	   surgeons	   depending	   on	   personal	   experience	   and	  
preference.	  Most	  surgeons	  would	  correct	  one	  side	  at	  a	  time	  with	  at	  least	  6	  months	  
wait	  in	  between	  surgeries.	  The	  first	  side	  should	  be	  evaluated	  in	  regard	  to	  possible	  
atrophy	   and/or	   recurrence	   before	   the	   contralateral	   side	   is	   operated	   on	   and	   the	  
appropriate	  method	  is	  chosen.	  	  
	  
Other	   surgical	   techniques	   used	   in	   the	   management	   of	   the	   intraabdominal	   testis	  
have	   been	  described	   such	   as	   laparoscopically	   or	   robot	   assisted	   orchidopexy	   and	  
autotransplantation	   of	   the	   testis.	   Autotransplantation,	   or	   microsurgery,	   is	   a	  
method	  where	  the	  spermatic	  vessels	  are	  anastomosed	  with	  vessels	  located	  in	  the	  
groin.	   In	   early	   orchidopexy	   the	   use	   of	   this	   technique	   is	   limited	   due	   to	   a	   small	  
diameter	  of	  the	  vessels.	  Also,	  the	  technique	  requires	  a	  skilled	  surgeon.	  	  
	  
1.10.4 Recurrences	  	  
Recurrences	  are	  well	  known	  and	  occur	  more	  often	  after	  surgery	  of	  intraabdominal	  
testes	   than	   more	   distal	   testes.	   The	   experience	   of	   the	   surgeon	   is	   also	   of	   major	  
importance.	   In	   our	   opinion	   recurrences	   often	   occur	   when	   using	   the	   inguinal	  
approach	   as	   a	   result	   of	   an	   inadequate	   retroperitoneal	   dissection	   with	   the	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consequence	   of	   persistent	   tension	   and	   subsequent	   retraction	   to	   a	   suprascrotal	  
position.	  	  The	  re-­‐operation	  carries	  a	  higher	  risk	  of	  damaging	  the	  vas	  deferens	  and	  
the	  vessels	  due	  to	  scarring	  tissue	  and	  deranged	  anatomy	  [91].	  	  
	  
1.10.5 Conclusion	  	  
In	  conclusion	  the	  success	  of	  surgery	  is	  defined	  as	  a	  scrotal	  position	  with	  no	  atrophy	  
and	   recurrence	   thus	   optimizing	   the	   potential	   for	   spermatogenesis	   and	   fertility	  
potential	   of	   the	   testis.	   The	   management	   of	   palpable	   testes	   is	   usually	   fairly	  
straightforward.	  In	  cases	  with	  intraabdominal	  testes,	  however,	  the	  method	  chosen	  
for	   orchidopexy	   varies	   more	   and	   is	   often	   based	   on	   the	   surgeon’s	   personal	  
experience	   and	   preference	   for	   the	   different	   techniques.	   More	   prospective	  






The	  success	  of	  surgical	  treatment	  is	  defined	  as	  testes	  in	  a	  scrotal	  position	  with	  no	  
atrophy,	   aiming	   at	   improved	   spermatogenesis.	   However,	   the	   final	   proof	   of	  
successful	  surgery	  would	  be	  normal	  sperm	  production	  in	  adulthood	  and	  achieved	  
paternity.	  Important	  parameters	  to	  consider	  when	  discussing	  fertility	  potential	  are	  
the	   age	   at	   treatment,	   hormonal	   parameters,	   testicular	   size	   and	   semen	   quality.	  
There	  are	  numerous	  retrospective	  reports	  on	  men	  with	  a	  history	  of	  cryptorchidism	  
investigating	  these	  parameters.	  	  
	  
1.11.2 Age	  at	  treatment	  and	  fertility	  
Numerous	  studies	  on	  adults	  with	  a	  history	  of	  cryptorchidism	  have	  been	  performed	  
[92-­‐96].	   	   These	   show	   that	   the	   paternity	   rate	   among	   men	   treated	   for	   bilateral	  
undescended	  testes	   is	  significantly	   lower	  compared	   to	  men	  treated	   for	  unilateral	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cryptorchidism	  and	   controls.	   Some	  have	   also	  demonstrated	   lower	   sperm	  counts,	  
lower	   inhibin	   B,	   and	   higher	   FSH	   and	   LH	   levels	   in	   men	   with	   bilateral	  
cryptorchidism.	  	  	  
	  
Studies	  on	  men	  with	  a	  history	  of	  unilateral	  cryptorchidism	  revealed	  that	  the	  age	  at	  
treatment,	   testicular	   size	   or	   location	   at	   the	   time	   of	   orchidopexy	   did	   not	  
significantly	  correlate	  with	  paternity	  rate,	  mean	  time	  to	  conception,	  semen	  quality	  
or	   hormone	   levels	   in	   adulthood	   compared	   to	   men	   in	   the	   general	   population.	  
However	   low	   values	   of	   inhibin	   B	   were	   shown	   to	   correlate	   with	   men	   having	  
compromised	   fertility	   in	   this	   group	   with	   unilateral	   cryptorchdism.	   Investigators	  
have	  concluded	  that	  indicators	  of	  high	  risk	  for	  infertility	  are	  low	  levels	  of	  inhibin	  B	  
together	  with	  high	  levels	  of	  FSH	  and	  decreased	  sperm	  counts.	  	  	  
	  
Other	   studies	   show	   a	   correlation	   between	   testicular	   volume	   and	   sperm	  
concentration	   but	   not	   with	   testicular	   position	   and	   age	   at	   surgery	   [97].	   On	   the	  
other	  hand,	  some	  studies	  on	  unilateral	  cryptorchidism	  show	  that	  treatment	  before	  
eight	  years	  of	  age	  lead	  to	  higher	  inhibin	  B	  levels,	  testicular	  volume	  and	  lower	  FSH	  
values	  compared	  to	  treatment	  given	  after	  this	  age	  [98,	  99].	  	  
	  
An	  extensive	  retrospective	  biopsy	  study	  by	  Cortes	  et	  al.	  on	  men	  who	  were	  younger	  
than	  twelve	  years	  of	  age	  at	  surgery	  showed	  that	  a	  lack	  of	  germ	  cells	  appeared	  from	  
18	  months	  of	  age	  at	  surgery.	  A	  normal	  sperm	  count	  was	  observed	  in	  19	  %	  of	  the	  
men	  with	  a	  history	  of	  bilateral	  cryptorchidism	  and	   for	  unilateral	  cases	   the	   figure	  
was	   83	   %.	   There	   was	   no	   correlation	   between	   sperm	   count	   and	   the	   number	   of	  
spermatogonia	   in	   the	   unilateral	   group,	  whereas	   it	   could	   be	   seen	   in	   the	   bilateral	  
group.	  If	  there	  were	  no	  germ	  cells	  at	  orchidopexy	  it	  was	  associated	  with	  80	  -­‐	  100	  %	  
risk	  of	   infertility	   for	   the	  bilateral	  group	  and	  33	  %	   for	   the	  unilateral	  group	  [100].	  
This	   study	   indicates	   that	   surgery	   should	   be	   performed	   early	   in	   life	   before	  
spermatogonia	  disappear,	  and	  that	  there	  is	  no	  correlation	  between	  semen	  quality	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in	  men	  with	  a	  history	  of	  unilateral	   cryptorchidism	  whereas	   in	  bilateral	   cases	   the	  
correlation	  is	  significant.	  	  The	  paternity	  rate	  was	  not	  investigated.	  	  
	  
Another	  study	  on	  men	  with	  previously	  unilateral	  undescended	   testes	  shows	   that	  
treatment	  around	  the	  age	  of	  two	  results	  in	  higher	  inhibin	  B	  and	  lower	  FSH	  levels	  
compared	  to	  later	  treatment,	  whereas	  a	  corresponding	  difference	  in	  semen	  quality	  
could	  not	  be	  proven	  [101].	  	  
	  
In	  a	  unique	  and	  interesting	  study	  thirteen	  men	  treated	  before	  one	  year	  of	  age	  were	  
compared	  with	  sixteen	  men	  who	  were	  operated	  on	  between	  ages	  one	  and	  two.	  The	  
results	  showed	  a	  significantly	  higher	  sperm	  density	  and	  motility	  in	  the	  group	  who	  
were	  treated	  before	  the	  age	  of	  one.	  On	  the	  other	  hand,	  there	  were	  no	  differences	  
between	  uni-­‐	  or	  bilateral	  cases,	  testicular	  volume,	  and	  number	  of	  spermatogonia	  or	  
position	   of	   the	   testes	   at	   time	   of	   orchidopexy.	   [102].	   This	   seems	   to	   be	   the	   only	  
retrospective	   study	   conducted	   on	   men	   treated	   at	   an	   age	   in	   accordance	   with	  
present	  recommendations,	  but	  it	  has	  some	  limitations:	  relatively	  few	  subjects	  were	  
included	  in	  the	  study	  and	  the	  reasons	  to	  perform	  orchidopexies	  before	  one	  year	  of	  
age	  are	  not	  clearly	  stated.	  	  
	  
Another	  study	  showed	  that	  men	  with	  a	  history	  of	  bilateral	  undescended	  testes	  who	  
had	   had	   an	   operation	   between	   ten	  months	   and	   four	   years	   of	   age	   had	   a	   normal	  
sperm	  count	  in	  76	  %	  of	  the	  cases	  compared	  to	  26	  %	  if	  the	  orchidopexy	  had	  been	  
done	  between	  four	  and	  ten	  years	  of	  age.	  In	  unilateral	  cases	  the	  figures	  were	  more	  
moderate:	  75	  %	  compared	  to	  71	  %	  respectively	  [103].	  Other	  investigators	  as	  well	  
confirm	  that	  surgery	  before	  the	  age	  of	  four	  in	  bilateral	  cases	  lead	  to	  better	  sperm	  




Gouveia	   et	   al.	   concluded	   that	   subfertile	   previously	   cryptorchid	   men	   had	   lower	  
inhibin	   B	   values,	   higher	   FSH	   and	   lower	   testicular	   volumes	   than	   subfertile	   men	  
without	  a	  history	  of	  cryptorchidism	  and	  controls.	   In	  addition,	  significantly	  higher	  
concentrations	  of	  inhibin	  B	  and	  sperm	  were	  observed	  in	  men	  who	  had	  undergone	  
orchidopexy	  before	  the	  age	  of	  four	  compared	  to	  those	  who	  had	  received	  treatment	  
later	  [105].	  
	  
Studies	  show	  that	  men	  with	  an	  absent	  testis	  (monorchidism)	  for	  whatever	  reason	  
do	   not	   have	   compromised	   fertility	   compared	   to	   the	   male	   population	   in	   general	  
[106,	  107].	  	  
	  
1.11.3 Conclusion	  
We	  have	  not	  found	  any	  prospective	  randomized	  studies	  on	  the	  influence	  of	  age	  at	  
treatment	  with	   follow-­‐up	  on	   fertility	   parameters	   into	   adulthood.	  However,	   there	  
are	   a	   many	   retrospective	   reports	   with	   contradictive	   results	   as	   regards	   the	  
parameters	   of	   importance	   to	   fertility	   outcome.	   One	   of	   the	   limitations	   of	   these	  
reports	   is	   the	   lack	   of	   clear	   definitions	   and	   nomenclature,	   resulting	   in	   a	   mix	   of	  
phenotypes,	  which	  may	  have	   influenced	   the	   results.	  Decades	   ago,	   treatment	  was	  
generally	   given	   at	   a	   higher	   age	   than	   is	   currently	   recommended,	  which	  makes	   it	  
very	   difficult	   to	   assess,	   on	   the	   basis	   of	   published	   studies,	   whether	   surgery	   in	  
infancy	  improves	  spermatogenesis.	  	  Some	  studies	  conducted	  on	  fairly	  young	  boys	  
indicate	   that	   early	   treatment	   is	   beneficial	   but	   fail	   to	   prove	   a	   positive	   effect	   on	  
fertility	  outcome.	  	  
	  
There	  is	  no	  doubt	  that	  bilateral	  cryptorchidism	  should	  be	  treated	  in	  childhood	  and	  
data	  suggest	  that	  early	  treatment	  is	  beneficial	  for	  future	  fertility	  and	  paternity.	  The	  
question	  is	  how	  early	  should	  surgery	  be	  done	  to	  achieve	  optimal	  fertility	  potential	  
in	  boys	  with	  bilateral	  cryptorchidism?	  Unilateral	  cryptorchidism	  accounts	  for	  more	  
than	   80	  %	   of	   all	   cases	   and	   early	   orchidopexy	  may	   be	   of	   importance	   for	   semen	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quality	   although	   it	   is	   not	   yet	   determined	   if	   this	   affects	   the	   paternity	   rate.	   In	  
summary,	   data	   are	   inconclusive	   on	   the	   effect	   on	   paternity	   in	   unilateral	  
cryptorchidism	   thus	  highlighting	   the	  need	   for	  prospective	   long-­‐term	  studies	   into	  
adulthood.	  	  	  
	  
	  
1.12 Markers	  of	  testicular	  function	  	  
1.12.1 Testicular	  histology	  	  
Most	   centres	   advocate	   early	   treatment	   of	   cryptorchidism	   based	   on	   studies	  
suggesting	  that	  early	  treatment	  is	  beneficial	  compared	  to	  later	  treatment.	  To	  finally	  
prove	  that	  an	  orchidopexy	  has	  been	  successful,	  however,	  normal	  sperm	  production	  
and	  achieved	  paternity	  in	  adulthood	  need	  to	  be	  verified	  in	  prospective,	  long-­‐term	  
follow-­‐up	  studies,	  which	  we	  currently	  lack.	  	  
	  
Consequently,	   an	   important	   issue	   is	   how	   to	  monitor	   the	   testicular	   function	   after	  
treatment	   and	   identify	   markers	   of	   importance	   for	   future	   fertility	   and	   paternity.	  
Testicular	  histology,	  hormonal	  markers	  and	  testicular	  volume	  are	  markers	  that	  can	  
be	  monitored	  during	  childhood,	  both	  before	  and	  after	  treatment.	  	  	  
	  
Normal	  germ	  cell	  development	  
The	  testis	  can	  be	  divided	   into	  tubular	  and	   interstitial	  compartments.	  The	  tubular	  
compartment	   contains	   the	   seminiferous	   tubules	   where	   spermatogenesis	   takes	  
place	   and	   consists	   of	   Sertoli	   and	   germ	   cells	   in	   different	   stages.	   The	   interstitial	  






Fig. 5. Histology of normal human testicular germ cells. Gonocytes, spermatogonia, 
spermatocytes, round and elongating spermatids are shown on the left side in cross 
sections of seminiferous tubules of a 1-year-old boy (a), a 5-year-old boy (b), a 12-
year-old boy (c) and a 23-year-old man (d). Postnatal male germ cells of pre-meiotic, 
meiotic and post-meiotic phases during spermatogenesis are shown in detail in the 
lower row (e). Abbreviations: gonocyte (G), spermatogonia (Spg); spermatocytes 
(Spc), round spermatids (rSpd), elongating and elongated spermatids (eSpd). Staining: 
haematoxylin/eosin (HE); Scale bar = 50 μm. (Stukenborg et al. 2010)	  
	  
	  
Germ	   cell	   development	   is	   a	   multistage	   process	   starting	   in	   the	   fetus	   and	   being	  
completed	   in	   puberty.	   During	   the	   fetal	   period	   gonocytes	   are	   formed	   to	   fetal	  
spermatogonia.	   At	   three	   months	   postnatally	   the	   fetal	   spermatogonia	   start	   to	  
transform	   into	   adult	   dark	   spermatogonia	   (Ad)	   and	   are	   normally	   completed	  
between	  six	  and	  twelve	  months	  of	  age.	  The	  maturation	  to	  Ad	  spermatogonia	  a	  few	  
months	   postnatally	   coincides	   with	   a	   period	   of	   rise	   in	   gonadotrophins	   and	  
testosterone	  referred	  to	  as	  minipuberty.	  The	  surge	   in	   testosterone	  causes	  Leydig	  
cell	  proliferation.	  Early	  stimulation	  of	  gonadotrophins	  on	  the	  testis	  is	  important	  for	  
the	  Sertoli,	  germ,	  and	  Leydig	  cell	   function.	  The	   first	  months	  of	   life	  are	  associated	  
with	  an	  increase	  in	  the	  total	  number	  of	  Sertoli	  and	  Leydig	  cells	  together	  with	  high	  
serum	  levels	  [108].	  At	  three	  years	  of	  age	  the	  spermatogonia	  transform	  to	  primary	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spermatocytes.	  From	  this	  age	  the	  testis	  remains	  quiescent	  until	  puberty	  when	  the	  
final	  steps	  of	  spermatogenesis	  with	  the	  transformation	  to	  spermatids	  will	  occur.	  	  
	  
The	  number	  of	  Leydig	  cells	  peak	  at	  the	  time	  of	  minipuberty,	  thereafter	  the	  number	  
of	   active	   Leydig	   cells	   decreases	   to	   a	  minimum	   at	   the	   age	   of	   two	   years	   and	   then	  
increases	   again	   at	   puberty	   [109-­‐111].	   In	   a	   post-­‐mortem	   study	   on	   boys	   with	   no	  
history	  of	  cryptorchidism	  the	  number	  of	  Sertoli	  cells	  per	  tubular	  cross	  section	  has	  
been	  shown	  to	  reach	  a	  maximum	  during	  the	  first	  year	  of	  life	  and	  then	  decrease	  in	  
number	  up	  to	  prepubertal	  ages	  [23,	  75].	  	  
	  
Post-­‐mortem	   studies	   on	   boys	   with	   no	   history	   of	   cryptorchidism	   show	   that	   the	  
number	  of	   spermatogonia	  decreases	   from	  six	  months	  of	   age	  and	   increases	  again	  
from	   about	   three	   years	   up	   to	   puberty	   [23,	   109,	   112].	   One	   of	   these	   studies	   also	  
shows	  that	  the	  reduction	  of	  germ	  cells	   in	  boys	  aged	  0	  -­‐	  1	  year	  compared	  to	  3	  -­‐	  4	  
year	  old	  boys	  was	  approximately	  5	  %	  for	  spermatogonia	  and	  approximately	  15	  %	  
for	  Sertoli	  cells	  [23].	  The	  age	  group	  examined	  in	  this	  study	  is	  fully	  comparable	  to	  
the	   randomization	   ages	   of	   cryptorchid	   boys	   in	   our	   own	   series	   and	   therefore	  
provides	  an	  excellent	  reference	  material.	  	  
	  
Germ	  cell	  development	  in	  cryptorchid	  testes	  
As	   a	   result	   of	   failure	   in	   the	   maturation	   process	   to	   Ad	   spermatogonia	   and	   to	  
spermatocytes,	   the	   germ	   cell	   development	   is	   abnormal	   in	   cryptorchid	   testes.	  
Hadziselimovic	   et	   al.	   have	   shown	   that	   the	   defect	   transformation	   will	   lead	   to	   a	  
disproportionate	  decrease	  of	  Ad	  spermatogonia	  with	  a	  substantial	   long-­‐term	  risk	  
of	  infertility.	  Interestingly,	  this	  reduction	  is	  more	  severe	  than	  the	  reduction	  of	  the	  
total	   number	   of	   germ	   cells.	   In	   addition	   there	   is	   also	   a	   failure	   in	   the	  maturation	  





Furthermore,	   the	  numbers	  of	  Leydig	  cells	  are	  reduced,	  maybe	  reflecting	  a	   lack	  of	  
gonadotrophin	   stimulation.	   The	   number	   of	   Sertoli	   cells	   has	   also	   been	   shown	   to	  
decrease,	  which	  leads	  to	  a	  diminished	  volume	  and	  diameter	  of	  seminiferous	  tubule.	  
Epididymal	   abnormalities	   have	   been	   observed	   possibly	   due	   to	   the	   effect	   of	   a	  
reduced	  number	  of	  Leydig	  cells	  and	  a	  hypothesized	  reduced	  paracrine	  testosterone	  
secretion	  on	  the	  testis	  and	  epididymis	  [71,	  113].	  	  
	  
It	   has	   been	   suggested	   that	   boys	   with	   cryptorchidism	   can	   be	   divided	   in	   two	  
subgroups:	   those	  with	  Leydig	  cells	   that	  respond	  with	  an	   increase	   in	   testosterone	  
levels	  after	  hCG	  stimulation	  and	  those	  with	  impaired	  Leydig	  cells	  responding	  with	  
an	   insufficient	   increase	   in	   testosterone	   plasma	   levels.	   The	   latter	   group	  with	   the	  
suboptimal	  Leydig	  cell	  capacity	  will	  also	  have	  a	  lower	  number	  of	  Ad	  spermatogonia	  
than	  the	  hCG	  responders	  [114].	  If	  this	  is	  an	  indication	  that	  preoperative	  hormonal	  
treatment	  is	  beneficial	  for	  spermatogenesis	  and	  whether	  hormonal	  treatment	  will	  
have	  a	  long	  lasting	  effect	  remains	  to	  be	  proven.	  
	  
In	   untreated	   cryptorchid	   boys	   a	   further	   degeneration	   of	   the	   testis	   occurs	   and	   is	  
considered	  to	  be	  caused	  by	  an	  elevated	  temperature	  in	  the	  groin,	  compared	  to	  a	  2	  -­‐	  
4°C	  lower	  temperature	  in	  the	  scrotum	  [115].	  One	  hypothesis	  is	  that	  heat	  induces	  a	  
defective	   transformation	   to	   spermatogonia.	   This	   has	   been	   confirmed	   in	   animal	  
studies	  where	  elevated	  temperatures	  proved	  to	  have	  adverse	  effects	  on	  the	  testis	  
[116-­‐118].	  	  
	  	  
1.12.2 Endocrine	  markers	  	  	  
Inhibin	  B,	  gonadotrophins	  and	  testosterone	  during	  childhood	  
Inhibin	  B	   is	   a	   direct	  marker	   of	   the	   Sertoli	   cell	   function,	   thus	   reflecting	   testicular	  
function.	   Serum	   inhibin	   B,	   gonadotrophins	   and	   testosterone	   increase	   during	   the	  
first	  months	  of	   life	  with	  a	  peak	  at	   two	  to	   three	  months	  of	  age	  (minipuberty)	  and	  
coincide	  with	  the	  maturation	  of	  germ	  cells.	  The	  first	  months	  of	  life	  are	  associated	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with	  an	  increased	  expression	  of	  Sertoli	  and	  Leydig	  cells	  together	  with	  high	  serum	  
levels	  [108].	  
	  
The	  secretion	  of	  inhibin	  B	  is	  stimulated	  by	  FSH,	  and	  suppresses	  FSH	  release	  from	  
the	   pituitary	   in	   a	   negative	   feedback	   loop.	   Thereafter	   gonadotrophins	   and	  
testosterone	   remain	   low	   until	   the	   onset	   of	   puberty,	   whereas	   inhibin	   B	   remains	  
higher	  and	  stays	  well	  measurable	  into	  adulthood.	  	  
	  
During	  the	  first	  months	  of	  life	  inhibin	  B	  correlates	  positively	  with	  gonadotrophins	  
and	   testosterone	  but	  at	  puberty	   the	   correlation	  with	   testosterone	  and	  LH	  ceases	  
and	  a	  clearly	  negative	  correlation	  with	  FSH	  develops	  and	  persists	  into	  adulthood.	  
Thus	  the	  correlation	  is	  switched	  by	  the	  onset	  of	  puberty.	  Other	  investigators	  have	  
not	  been	  able	  to	  show	  a	  correlation	  between	  inhibin	  B	  and	  FSH	  in	  childhood	  [108,	  
119-­‐122].	  	  
	  
Hormones	  and	  cryptorchidism	  
Studies	   have	   been	   conducted	   on	   boys	   with	   cryptorchidism	   with	   contradictive	  
results.	   One	   investigation	   showed	   that	   there	   were	   no	   significant	   differences	   in	  
levels	   of	   inhibin	   B,	   gonadotrophins	   and	   testosterone	   compared	   with	   normal	  
prepubertal	   boys,	   also	   there	   was	   no	   difference	   between	   uni-­‐	   and	   bilateral	  
cryptorchidism	  	  [123].	  However,	  another	  report	  showed	  that	  boys	  with	  unilaterally	  
undescended	  testes	  under	  the	  age	  of	  4	  years	  had	  lower	  basal	  inhibin	  B	  and	  higher	  
FSH	   levels	   than	   controls.	   Inhibin	   B	   further	   correlated	   to	   the	   number	   of	  
spermatogonia	   in	  the	  undescended	  testes	  after	  preoperative	  hormonal	   treatment	  
[124].	  	  
	  
Another	  study	  by	  Cortes	  et	  al.	  on	  25	  boys	  with	  bilateral	  cryptorchidism,	  who	  had	  
undergone	   an	   operation	   at	   an	   average	   age	   of	   2.5	   years,	   revealed	   that	   a	   reduced	  
number	  of	  spermatogonia	  could	  be	  correlated	  with	   low	   levels	  of	   inhibin	  B	  at	   the	  
time	  of	  surgery.	  In	  bilateral	  cryptorchid	  boys	  inhibin	  B	  levels	  correlated	  negatively	  
	  31	  
	  
with	  FSH.	  The	  researchers	  suggested	  that	  boys	  with	  low	  inhibin	  B	  and	  FSH	  levels	  
together	   with	   a	   poor	   germ	   cell	   count	   should	   be	   evaluated	   in	   regard	   to	  
hypogonadotrophic	  hypogonadism	  	  [125].	  
	  
1.12.3 Testicular	  volume	  	  	  
The	   increase	   in	   testicular	   volume	   from	   approximately	   two	  ml	   before	   puberty	   to	  
more	  than	  fifteen	  ml	  after	  puberty	  is	  mainly	  attributed	  to	  the	  increase	  of	  germ	  cells	  
and	  Sertoli	  cell	  volume	  leading	  to	  an	  increased	  tubule	  diameter.	  	  
	  
Several	   methods	   for	   measuring	   testicular	   volume	   in	   adolescents	   have	   been	  
described	   and	   proven	   useful	   [126-­‐129].	   Testicular	   volume	   has	   always	   been	  
considered	   to	   reflect	   testicular	   function.	   Incomplete	   spermatogenesis	   may	  
therefore	   result	   in	   reduced	   volume	   and	   compromised	   spermatogenesis	   in	   adults	  
[24,	  97,	  130,	  131].	  	  
	  	  
In	  a	  retrospective	  study	  723	  boys	  with	  uni-­‐	  and	  bilateral	  undescended	  testes	  were	  
operated	  on	  before	  the	  age	  of	  nine	  but	  testicular	  volume	  could	  not	  predict	  the	  germ	  
cell	  count	  in	  cryptorchid	  boys	  [132].	  As	  shown	  in	  a	  number	  of	  studies	  the	  testicular	  
volume	   is	   often	   reduced	   in	   men	   with	   compromised	   fertility,	   but	   not	   always	  
correlating	   with	   spermiograms	   and	   paternity	   as	   we	   discuss	   in	   the	   section	   on	  
fertility.	  	  
	  
Ultrasound	   has	   shown	   to	   be	   a	   reliable	   and	   reproducible	   method	   to	   determine	  
testicular	   volume,	   also	   during	   the	   first	   year	   of	   life	   [133,	   134].	   In	   one	   study	   on	  
adults,	  ruler	  measurements	  were	  compared	  to	  ultrasound	  showing	  that	  the	  results	  







1.12.4 	  Semen	  quality	  	  
Semen	  quality	  is	  an	  important	  marker	  for	  assessing	  testicular	  function	  in	  men	  with	  
compromised	   fertility,	   but	   it	   will	   only	   be	   discussed	   briefly	   in	   this	   report.	   Basic	  
semen	   parameters	   include	   motility,	   vitality,	   number	   and	   concentration	   and	  
morphology.	  Testicular	  function	  or	  spermatogenesis	  is	  not	  the	  only	  determinant	  of	  
sperm	   concentration	   in	   the	   ejaculate.	   Factors	   like	   the	   duration	   of	   sexual	  
abstinence,	   fever,	   stress,	   medical	   conditions	   also	   play	   a	   role,	   and	   consequently	  
there	   is	   a	   large	   intra-­‐individual	   variation	   [135,	   136].	   There	   are	   numerous	  
retrospective	   studies	   on	   men	   with	   previous	   cryptorchidism	   with	   contradictive	  




From	   our	   point	   of	   view	   repeated	   biopsies	   after	   an	   orchidopexy	   to	   evaluate	   the	  
actual	   treatment	   is	  not	   an	  option,	  but	  biopsies	   taken	  at	   the	  orchidopexy	  provide	  
valuable	  data	  and	  can	  be	  correlated	  with	  testicular	  volume	  and	  hormone	  levels	  at	  
the	  time	  of	  surgery.	  	  
	  
Serum	  levels	  of	  inhibin	  B	  and	  testosterone	  reflect	  the	  output	  of	  both	  testes	  and	  are	  
therefore	  difficult	  to	  interpret	  in	  unilateral	  cryptorchidism,	  which	  accounts	  for	  the	  
majority	  of	   all	   cases.	   In	  bilateral	   cases,	   however,	   these	   figures	   could	  prove	   to	  be	  
important.	  	  
	  
Serum	  inhibin	  B	  is	  considered	  to	  be	  a	  marker	  of	  Sertoli	  cell	  function,	  but	  studies	  on	  
cryptorchid	  boys	  show	  contradictive	  results.	  Consequently	  the	  predictive	  value	  of	  
prepubertal	   inhibin	  B	  for	  the	  quality	  of	  spermatogenesis	  in	  adulthood	  remains	  to	  




In	   our	   opinion,	   measurements	   of	   testicular	   volume	   seem	   to	   be	   an	   acceptable	  
surrogate	   for	   repeated	  biopsies	   since	   studies	   show	   they	  correlate	  with	   testicular	  
function,	   though	   not	   always	   with	   spermiograms	   and	   paternity.	   Consequently,	   it	  
seems	  reasonable	  to	  follow	  boys	  before	  and	  after	  treatment	  and	  into	  puberty	  with	  
longitudinal	  ultrasound	  measurements.	  	  
	  
	  
1.13 Age	  at	  treatment	  	  
As	  discussed	  previously	  the	  optimal	  time	  for	  surgery	  for	  cryptorchidism	  has	  not	  
yet	  been	  established,	  however	  most	  agree	  that	  treatment	  should	  be	  offered	  early	  
in	  life.	  	  
	  
The	   general	   consensus	   on	   treatment	   before	   age	   one	   is	   based	   on	   mounting	  
indirect	  proof	  even	  though	  there	  are	  no	  prospective	  studies	  where	  boys	  actually	  
have	  been	  randomized	  to	  surgery	  at	  different	  ages	  and	  then	  been	  followed	  with	  
markers	   of	   testicular	   function	   throughout	   childhood	   and	   puberty.	  Most	   studies	  
are	  conducted	  on	  children	  that	  are	  older	  than	  one	  year	  of	  age,	  a	  period	  when	  the	  
testis	  is	  quite	  dormant	  compared	  to	  the	  first	  months	  of	  life.	  	  
	  
A	  single	  study	  has	  actually	  conducted	  a	  follow-­‐up	  biopsy	  after	  initial	  biopsy	  taken	  
at	   time	   of	   surgery.	   A	   total	   of	   670	   biopsies	  were	   taken	   including	   biopsies	   on	   the	  
scrotal	   testes.	   The	  majority	   of	   the	   treated	   boys	  were	   older	   than	   3	   years	   of	   age.	  
Histological	   evaluation	   revealed	   that	   at	   time	   of	   orchidopexy	   the	   germ	   cell	  
population	  was	  affected	  in	  nearly	  all	  undescended	  testes	  and	  interestingly	  also	  in	  
30	  percent	  of	  the	  normal	  scrotal	  normal	  testes.	  No	  difference	  was	  noted	  between	  
uni-­‐	  or	  bilateral	  cryptorchidism	  except	  in	  bilateral	  intraabdominal	  cases	  where	  the	  
germ	  cell	  loss	  was	  severe.	  A	  repeated	  biopsy	  was	  performed	  months	  or	  years	  after	  
the	   initial	   biopsy	   in	   18	   unilateral	   and	   24	   bilateral	   cases.	   Interestingly	   after	  
histological	   evaluation	   no	   significant	   difference	   in	   the	   number	   of	   spermatogonia	  
was	  observed,	   suggesting	   that	   catch-­‐up	   spermatogenesis	  did	  not	  occur.	  The	  only	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difference	  was	   the	  size	  of	   the	   tubular	  diameter.	  The	  authors	  concluded	  based	  on	  
these	  results	  that	  no	  recommendation	  on	  age	  of	  treatment	  could	  be	  given	  [137].	  
	  
One	   limitation	  of	   this	   study	   is	   that	   the	  biopsies	  were	   taken	   at	   a	   higher	   age	   than	  
recommendations	   today	   for	  orchidopexy	  meaning	   that	   the	   important	  maturation	  
step	   to	   spermatogonia	   had	   already	   taken	   place	   in	   these	   biopsied	   boys,	   in	   other	  
words	  the	  “damage	  was	  already	  done”.	  	  
	  
The	   fact	   that	   the	   contralateral	   scrotal	   testes	   were	   affected	   in	   30	   percent	   of	   the	  
cases	   is	   difficult	   to	   explain	   and	   also	   these	   results	   have	   not	   been	   reproduced	   in	  
other	  studies.	  The	  study	   is	   retrospective	  and	   thus	  carries	   limitations	  as	   such,	   for	  
example	   boys	  with	   acquired	   undescended	   testes	   and	   boys	  with	   retractile	   testes	  
might	  very	  well	  be	  included	  in	  the	  patient	  material	  hence	  influencing	  the	  results.	  	  
	  
However	   other	   studies	   have	   suggested	   that	   early	   treatment	   is	   beneficiary	  
compared	  to	  late	  treatment.	  	  
	  
In	  an	  excellent	  retrospective	  study	  by	  Tasian	  et	  al	  274	  biopsies	  were	  reviewed	  and	  
correlated	  to	  age	  at	  surgery.	  The	  mean	  age	  for	  unilateral	  and	  bilateral	  orchidopexy	  
was	   between	   three	   and	   four	   years	   of	   age.	   Surprisingly	   the	   authors	   reported	   a	  
significant	  2	  percent	  risk	  per	  month	  of	  germ	  cell	  loss	  and	  1	  percent	  risk	  per	  month	  
of	   Leydig	   cell	   loss	   for	   each	  month	   a	   testis	   remained	   in	   a	   retained	  position.	  They	  
furthermore	  concluded	   that	   there	   is	  a	  50	  percent	  risk	   for	  more	  severe	  germ	  and	  
Leydig	  cell	  los	  in	  cases	  of	  non-­‐palpable	  testes.	  They	  were	  unable	  to	  do	  correlation	  
studies	  on	  semen,	  hormonal	  or	  paternity	  parameters	  [138].	  	  
	  
One	  recent	  study	  investigated	  biopsies	  taken	  from	  29	  intraabdominal	  testes.	  Result	  
showed	  decreased	  mean	  diameter	  of	  seminiferous	  tubules	  and	  germ	  cell	  depletion	  
increasing	   with	   age	   at	   orchidopexy.	   Treatment	   after	   3	   years	   of	   age	   predicted	  




An	   extensive	   retrospective	   study	   by	   Cortes	   et	   al	   showed	   that	   lack	   of	   germ	   cells	  
appeared	  from	  18	  months	  of	  age	  at	  surgery,	  thus	  indicating	  that	  surgery	  should	  be	  
performed	   before	   this	   age.	   Findings	   in	   the	   study	   could	   be	   correlated	   to	   semen	  
quality	  in	  both	  unilateral	  and	  bilateral	  cryptorchidism	  [100].	  	  
	  
1.13.1 Conclusion	  
Even	   though	   results	   show	   contradictive	   results,	   most	   studies	   indicate	   that	   the	  
earlier	  the	  surgery	  is	  performed	  the	  less	  is	  the	  germ	  and	  Leydig	  cell	  depletion,	  the	  
















2.1	  Study	  I	  and	  II	  
To	  investigate	  whether	  surgical	  treatment	  at	  nine	  months	  compared	  to	  treatment	  
at	  three	  years	  of	  age	  of	  boys	  with	  palpable	  congenital	  unilateral	  cryptorchidism	  is	  
followed	  by	  an	  improved	  testicular	  growth	  up	  to	  the	  age	  of	  four	  years.	  
	  
2.2	  Study	  III	  
To	  examine	  the	  natural	  course	  of	  spontaneously	  descended	  testes	  and	  investigate	  
whether	  the	  testicular	  growth	  from	  birth	  to	  five	  years	  of	  age	  are	  different	  to	  scrotal	  
testes	  and	  to	  testes	  surgically	  treated	  at	  nine	  months	  and	  three	  years.	  	  
	  
2.3	  	  	  Study	  IV	  
To	   investigate	   in	   morphometric	   and	   volumetric	   studies	   whether	   surgery	   at	   9	  
months	  would	  be	  more	  beneficial	  than	  at	  3	  years	  and	  furthermore	  identify	  possible	  















3.	  Study	  design	  
The	   randomized	   study	  began	   in	  1998	  at	  Astrid	  Lindgren´s	  Children´s	  Hospital	   at	  
the	  Karolinska	  University	  Hospital.	  All	  the	  departments	  of	  obstetrics	  in	  Stockholm	  
were	  informed	  about	  the	  study	  and	  were	  invited	  to	  refer	  all	  newborn	  boys	  with	  a	  
suspicion	  of	  congenital	  cryptorchidism	  to	  the	  Department	  of	  Pediatric	  Surgery.	  	  
	  
Boys	   with	   recognized	   syndromes,	   other	   birth	   defects,	   or	   other	   pathological	  
conditions	  afflicting	  the	  external	  genitalia,	  prematurity	  (<37	  weeks	  of	  gestation)	  or	  
prior	  groin	  surgery	  were	  excluded	  from	  the	  study.	  
	  
After	  confirmation	  of	  congenital	  cryptorchidism	  and	  consent	  from	  the	  parents	  the	  
boy	  was	  enrolled	  in	  the	  study.	  The	  major	  part	  of	  the	  boys	  were	  included	  at	  age	  0-­‐3	  
weeks,	   however	   some	   boys	   were	   not	   included	   until	   age	   6	   months	   due	   to	   late	  
referral	   or	   missed	   appointments.	   According	   to	   their	   neonatal	   record	   these	   late	  
referred	  boys	  were	  cryptorchid	  from	  birth.	  	  
	  
The	  boys	  were	  followed	  with	  clinical	  examinations,	  blood	  samplings	  for	  hormone	  
evaluation	   and	   ultrasound	   examinations	   at	   0-­‐3	   ages	  weeks	   and	   at	   ages	   2	   and	   6	  
months,	  1	  one	  year	  and	  yearly	  up	  to	  5	  years	  of	  age	  (all	   time	  points	  +/-­‐	  2	  weeks)	  
and	  thereafter	  at	  11	  years	  of	  age.	  The	  data	  in	  this	  thesis	  report	  include	  follow-­‐up	  







Table 1. Study design from birth up through puberty. Data gathered up to 5 years of 
age is presented in this thesis report (study I to IV). 
	  
3.1	  	  	  Ethical	  permissions	  
The	  Ethics	  Committee	  of	  the	  Karolinska	  Institute	  approved	  the	  studies	  and	  written	  
consent	  was	  obtained	  from	  the	  participating	  families.	  
	  
3.2	  	  	  Phenotypes	  and	  groups	  
Enrolment	  ages	  0-­‐3	  weeks	  and	  6	  months	  
The	   included	   boys	   were	   sub-­‐grouped	   into	   palpable	   or	   non-­‐palpable	   uni-­‐	   or	  
bilateral	  cryptorchidism.	  
	  
Some	   boys	   could	   not	   be	   classified	   due	   to	   an	   inhomogeneous	   phenotype;	   for	  
example	   one	   palpable	   testis	   and	   a	   non-­‐palpable	   contralateral	   testis,	   these	   were	  
included	  in	  a	  “mixed”	  group.	  	  
Study design	  
+/	  -	  2 weeks	   Clinical exam.	   Ultrasound	   FSH, LH, 	  
Testosteron, 	  
Inhibin B	  
Randomis. 9 	  
mo/3 yrs	  
0	  -	  3 weeks	   X	   X	   X	  
2 months	   X	   X	  
6 months	   X	   X	   X	   X	  
12 months	   X	   X	   X	  
Yearly to 5 	  
yrs,	  11 yrs 	  
and after 	  
puberty	  
X	   X	   X	  
	  39	  
	  
Follow-­‐up	  at	  2	  months	  
Boys	   that	   showed	  spontaneous	  descent	  at	   this	  age	  were	   included	  and	  were	  seen	  
again	  at	  age	  1	  year.	  	  
	  
Follow-­‐up	  at	  6	  months	  (randomization	  age)	  
At	  age	  6	  months	  the	  boys	  that	  still	  were	  cryptorchid	  were	  randomized	  to	  surgery	  
at	   either	  9	  months	  or	  3	  years	  of	   age.	   	  Boys	  with	  ascent	   after	   initial	   spontaneous	  
descent	  (recurrent	  cryptorchidism)	  were	  included	  upon	  presentation.	  
	  
Some	  boys	  changed	  group	  and	  were	  added	  to	  the	  mixed	  group	  due	  to	  an	  acquired	  
inhomogeneous	  phenotype;	  for	  example	  a	  boy	  with	  spontaneous	  descent	  one	  side	  
and	  cryptorchid	  on	  the	  contralateral	  side.	  	  Consequently	  the	  mixed	  group	  changed	  
in	   the	  number	  of	   included	  boys	  during	   the	   follow-­‐up	  period	  until	   the	  boys	  were	  
operated	  on.	  	  
	  
Surgery	  at	  9	  months	  or	  3	  years	  of	  age	  
At	   surgery	   the	   non-­‐palpable	   group	   was	   separated	   into	   uni-­‐	   or	   bilateral	  
intraabdominal	   or	  monorchid	   groups.	   Boys	  with	   recurrent	   cryptorchidism	  were	  
operated	  on	  upon	  presentation.	  	  
	  
Change	  of	  study	  design	  in	  1998	  
The	  Nordic	  onsensus	  report	  published	  in	  2007	  recommended	  surgery	  before	  age	  1	  
year	   [20].	   Based	   on	   this	   recommendation	   we	   decided	   from	   2008	   to	   operate	   all	  
boys	  at	  9	  months	  of	  age.	  	  
	  
Furthermore	   we	   ceased	   to	   recruit	   boys	   with	   unilateral	   palpable	   cryptorchidism	  
into	  the	  study	  due	  to	  the	  fact	  that	  we	  had	  a	  considerable	  number	  of	  boys	  with	  this	  
type	   of	   cryptorchidism	   enrolled.	   	   Recruitment	   only	   continued	   in	   boys	   with	   less	  
	  40	  
	  
frequent	   phenotypes;	   non-­‐palpable	   and	   bilateral	   cases.	   In	   summary	   these	  
measures	   lead	   to	   a	   skewed	   distribution	   in	   the	   patient	   material	   in	   bilateral,	  


























4.	  Patient	  material	  	  
The	   different	   subgroups	   and	   number	   of	   included	   boys	   are	   shown	   in	   table	   2.	   In	  
study	  I	  to	  IV	  the	  study	  populations	  varied	  as	  presented	  in	  each	  study.	  	  
 
Table 2. The total number of included and categorized boys.  
 
Groups N 
Unilateral palp. treated at 9 mo. 78 
Unilateral palp. treated at 3 y. 85 
Bilateral palp. treated at 9 mo. 28 
Bilateral palpable treated at 3 y. 8 
Intraabdominal treated at 9 mo. 20 
Intraabdominal treated at 3 y. 15 
Monorchid treated at 9 mo. 27 
Monorchid treated at 3 y. 17 
Spontaneous descent unilateral 71 
Ascending (recurrent) 20 
Mixed  57 
	  
	  
4.1	  	  	  Study	  I	  
Boys	   with	   unilateral	   palpable	   undescended	   testes	   randomized	   to	   surgery	   at	   9	  
months	  (n=70)	  of	  age	  were	  examined	  from	  birth	  (0-­‐3	  weeks)	  until	  2	  years	  of	  age	  
with	  longitudinal	  ultrasound	  measurements	  of	  testicular	  volume	  and	  compared	  to	  
	  42	  
	  
yet	   non-­‐treated	   boys	   (n=79)	   with	   unilateral	   palpable	   undescended	   testes	   also	  
followed	  until	  2	  years	  of	  age.	  	  
	  
4.2	  	  	  Study	  II	  	  
Boys	   with	   unilateral	   palpable	   undescended	   testes	   randomized	   to	   surgery	   at	   9	  
months	  (n=72)	  and	  3	  years	  (n=83)	  of	  age	  were	  examined	  from	  birth	  (0-­‐3	  weeks)	  
and	  until	  4	  years	  of	  age	  with	   longitudinal	  ultrasound	  measurements	  of	   testicular	  
volume.	  
	  
4.3	  	  	  Study	  III	  	  
Boys	  with	  spontaneous	  unilateral	  descent	  (n=71)	  were	  examined	  from	  birth	  (0-­‐3	  
weeks)	  and	  until	   five	  years	  of	  age	  with	   longitudinal	  ultrasound	  measurements	  of	  
testicular	  volume	  and	  compared	  to	  boys	  with	  unilateral	  palpable	  testes	  that	  were	  
operated	  on	  at	  age	  9	  months	  (n=78)	  and	  3	  years	  (n=85)	  of	  age.	  Boys	  with	   initial	  
spontaneous	  descent	  followed	  by	  ascense	  (n=20)	  were	  included.	  	  
	  
4.4	  	  	  Study	  IV	  	  	  
The	   patient	   material	   in	   study	   IV	   included	   boys	   with	   spontaneous	   descent,	  
unilateral	   and	   bilateral	   cryptorchidism.	   The	   groups	   were	   investigated	   regarding	  
morphological,	  volumetric	  and	  endocrine	  data.	  	  
	  
Morphometric	  part	  
A	   total	   of	  213	  biopsies	   from	  215	  boys	  were	   collected	  and	   testicular	   volume	  was	  






Table 3. The number of biopsies obtained in boys treated at 9 months and at 3 years is 
shown. 
	  
Group	   Biopsies	  
Unilateral	  
palpable	  
Surg.	  9	  mo.	  	   73	  
Surg.	  3	  y.	   74	  
Bilateral	  
palpable	  
Surg.	  9	  mo.	   27	  
Surg.	  3	  y.	   6	  
Intra-­‐
abdominal	  
Surg.	  9	  mo.	   21	  
Surg.	  3	  y.	   12	  
	  
	  
A	  number	  of	  boys	  with	  bilateral	  cryptorchidism	  were	  as	  discussed	  before	  included	  
in	  the	  mixed	  group	  due	  to	  the	  fact	  that	  both	  sides	  could	  not	  be	  surgically	  corrected	  
at	  the	  same	  occasion,	  often	  one	  side	  was	  corrected	  at	  9	  months	  and	  the	  second	  side	  
was	  treated	  later,	  thus	  resulting	  in	  a	  inhomogeneous	  phenotype	  and	  therefore	  the	  
boys	  were	  added	  to	  the	  mixed	  group.	  However	  in	  the	  biopsy	  study	  some	  of	  these	  
boys	   were	   included	   since	   the	   biopsies	   represent	   data	   from	   boys	   with	   bilateral	  
cryptorchidism	  at	  9	  months	  of	  age,	  even	   though	   the	  other	  contralateral	   side	  was	  
operated	  on	  at	  another	  age.	  	  
	  
Endocrine	  part	  
Blood	  samples	  for	  analysis	  of	  inhibin	  B	  and	  FSH	  levels	  were	  collected	  at	  ages	  0-­‐3	  
weeks,	  2	  and	  6	  months	  and	  1,	  2	  and	  4	  years	  of	  age.	  LH	  and	  testosterone	  were	  only	  
analyzed	  at	  ages	  0-­‐3	  weeks,	  2	  and	  6	  months	   since	  blood	   levels	  at	   following	  ages	  
were	  very	  low	  and	  often	  not	  measurable.	  To	  investigate	  the	  relationship	  between	  
inhibin	  B	   and	  FSH	   all	  measurements	   from	  all	   groups	  were	   added	   together	   at	   all	  




The	   boys	   were	   grouped	   and	   blood	   sampling	   was	   performed	   according	   to	   the	  
following:	  Preoperative	  (not	  yet	  operated	  on)	  and	  postoperative	  boys	  (operated	  on)	  
with	   unilateral	   palpable	   and	   non-­‐palpable	   intraabdominal	   and	   monorchid	  
undescended	   testes.	  Boys	  with	  bilateral	  palpable	  undescended	   testes	  at	  pre-­‐	  and	  
postoperative	  ages.	  Boys	  with	  spontaneous	  descent	  and	  all	  boys	  lumped	  together.	  
	  
Table 4. Table shows the different subgroups and ages at blood sampling. 
	  
Group	   Ages	  	  
Preoperative	  	   0-­‐3	  weeks,	  2	  and	  6	  mo.	  and	  1	  and	  2	  y.	  
Postoperative	   1,	  2	  and	  4	  years	  
Bilateral	   0-­‐3	  weeks,	  2	  and	  6	  mo.	  and	  4	  years	  
Spontaneous	  descent	   0-­‐3	  weeks,	  2	  and	  6	  mo.	  and	  1,	  2	  and	  4	  y.	  




Ultrasound	  measurements	  from	  patients	  from	  groups	  palpable	  unilateral,	  bilateral	  
and	  non-­‐palpable	  unilateral	  intraabdominal	  testes	  were	  studied	  from	  birth	  and	  up	  













5.1	  	  	  Surgical	  methods	  
The	  surgical	  methods	  used	  in	  our	  series	  of	  patients	  included	  a	  standardized	  open	  
single-­‐staged	   inguinal	   method	   for	   all	   palpable	   testes	   and	   non-­‐palpable	  
intraabdominal	  testes	  after	  preceding	  diagnostic	  laparoscopy.	  	  
	  
In	  our	  series	  we	  did	  not	  use	  the	  single-­‐incision	  transscrotal	  approach	  even	  though	  
some	  testes	  were	  suitable	  for	  the	  use	  of	  this	  method,	  the	  reason	  for	  this	  was	  that	  
we	  wished	  to	  standardize	  the	  procedure.	  	  
	  
A	  Fowler-­‐Stephens	  open	  single-­‐step	  procedure	  (as	  described	  before)	  with	  division	  
of	  the	  vessels	  was	  done	  in	  a	  few	  cases	  where	  sufficient	  length	  to	  scrotum	  could	  not	  
be	   achieved.	   An	   inguinal	   retroperitoneal	   dissection	   was	   always	   tried	   before	   the	  
Fowler-­‐Stephens	  procedure	  was	  done.	  	  
	  
An	  initial	  diagnostic	  laparoscopy	  was	  performed	  in	  boys	  with	  non-­‐palpable	  testes,	  
in	   some	  cases	  an	  atrophic	   testis	  was	   removed	  during	   laparoscopy	  or	   through	  an	  
inguinal	  approach.	   	  The	  same	  surgeon	  (CK)	  performed	  more	  than	  95	  %	  of	  all	   the	  
surgical	  procedures.	  
	  
Open	  inguinal	  approach	  
A	   transverse	   incision	   in	   the	   groin	   1-­‐2	   cm	   proximal	   to	   the	   pubic	   bone	  was	   done	  
(over	  the	  inguinal	  ring),	  in	  some	  cases	  with	  intraabdominal	  testes	  the	  incision	  was	  




The	   superficial	   fascia	   (Scarpa)	  was	   incised	   and	   the	   external	   oblique	   aponeurosis	  
was	   identified.	   If	   necessary	   the	   testis	   was	   then	   freed	   distally	   from	   the	  
gubernaculum	  attachment	  and	  proximally	  around	  the	  external	  ring.	  	  
	  
The	   extern	   oblique	   aponeurosis	   was	   incised	   in	   the	   direction	   of	   the	   spermatic	  
vessels	  approximately	  1-­‐3	  cm	  depending	  on	   the	  need,	  caution	  being	  made	   to	   the	  
ileoinguinal	  nerve.	  Further	  blunt	  and	  sharp	  dissection	  around	  the	  spermatic	  cord	  
and	  proximally	  around	  the	  internal	  ring	  was	  done.	  	  
	  
The	   tunica	   vaginalis	   was	   then	   opened	   and	   the	   testis,	   epididymis,	   vessels,	   vas	  
deferens	   and	   other	   abnormalities	   were	   described.	   In	   many	   cases	   a	   hydatid	   of	  
Morgagni	  was	  identified	  and	  removed.	  Thereafter	  the	  testis	  was	  measured	  with	  a	  
ruler	  (length,	  width,	  height).	  	  
	  
The	   spermatic	   vessels	   and	   the	   vas	   deferens	   located	   in	   the	   retroperitoneal	   space	  
were	   carefully	   dissected	   away	   from	   the	   peritoneum.	   The	   hernial	   sac	   was	   not	  
ligated	  at	   this	  point;	   it	  was	  kept	  clamped	  and	   lifted	  thus	   facilitating	  the	  access	   to	  
the	   retroperitoneal	   space.	   If	   the	   retroperitoneal	   space	  was	   not	   clearly	   identified	  
optimal	  high	  dissection	  was	  harder	  to	  achieve.	  	  
	  
In	   cases	  of	   intraabdominal	   testes	  a	  blunt	  and	  sharp	   retroperitoneal	  dissection	  of	  
tissues	  surrounding	  the	  spermatic	  vessels	  was	  done,	  the	  higher	  the	  location	  of	  the	  
testis	   the	   more	   extensive	   and	   proximal	   dissection.	   This	   step	   of	   the	   surgical	  
procedure	   is	   sometimes	   difficult	   and	   crucial	   for	   achieving	   optimal	   length	   of	   the	  
vessel	   for	   the	   testis	   to	   be	   placed	   in	   the	   scrotum	  without	   the	   need	   of	   a	   Fowler-­‐
Stephens	  procedure.	  	  
	  47	  
	  
Next	  the	  hernial	  sac	  was	  ligated.	  Additional	  length	  of	  a	  few	  mm	  of	  the	  vessels	  was	  
sometimes	   achieved	   by	   the	   transposition	   of	   vas	   deferens	   and	   spermatic	   vessels	  
under	  inguinal	  vessels.	  	  
	  
The	  orchidopexy	  was	  achieved	  by	  creating	  a	  subdartos	  pouch	  for	  the	  testis	  in	  the	  
scrotum.	  This	  was	  done	  by	  a	  transversal	  scrotal	  skin	  incision,	  about	  1	  cm	  in	  length,	  
followed	  by	  a	  blunt	  dissection	  both	  proximally	  (to	  prevent	  an	  upward	  traction	  of	  
the	   scrotal	   skin)	   and	   distally	   under	   the	   scrotal	   skin	   from	   the	   incision.	   Next	   the	  
subcutaneous	  scrotal	  fascia	  was	  incised	  where	  a	  suture	  was	  placed	  un-­‐knotted	  in	  
the	  “corner”	  of	  the	  dartos	  fascia.	  	  
	  
A	  passage	  or	  tunnel	  was	  then	  bluntly	  created	  with	  the	  use	  of	  the	  index	  finger	  from	  
the	   inguinal	   incision	   down	   to	   the	   scrotal	   incision.	   A	   surgical	   clamp	   was	   then	  
inserted	   through	   the	   scrotal	   incision	   touching	   the	   index	   finger;	   this	  position	  was	  
kept	   while	   retracting	   the	   surgical	   clamp	   towards	   the	   inguinal	   incision	  
simultaneously	  withdrawing	  the	  finger,	  still	  keeping	  the	  contact	  between	  the	  finger	  
and	  the	  instrument.	  The	  testis	  was	  then	  placed	  and	  fixed	  in	  the	  surgical	  clamp	  by	  
holding	  the	  testis	  in	  the	  epididymal	  ligament,	  this	  was	  followed	  by	  a	  retraction	  of	  
the	  clamp	  with	  the	  testis	  through	  the	  passage	  back	  to	  the	  scrotal	  incision.	  	  
	  
The	  previously	  placed	  resorbable	  unligated	  suture	  was	  used	  to	  narrow	  the	  width	  
of	   the	   dartos	   fascia	   and	   finally	   ligated	   to	   prevent	   the	   testis	   from	   retracting	   to	   a	  
retained	  position.	  Sutures	  in	  the	  capsule	  of	  the	  testis	  for	  fixation	  were	  avoided	  at	  
all	  times.	  Finally	  the	  skin	  incisions,	  external	  aponeurosis,	  subcutaneous	  tissue	  was	  
closed	  using	  resorbable	  sutures.	  According	  to	  the	  study	  design	  a	  testicular	  biopsy	  





Fig.6. Series of pictures illustrating some of the different steps in an open single-staged 
scrotal orchidopexy	  
	  
So	  in	  summary,	  scrotal	  position	  for	  the	  palpable	  testes	  is	  often	  easy	  to	  achieve.	  The	  
surgical	   challenge	   to	   accomplish	   this	   is	   for	   the	   intraabdominal	   testes.	   The	  
identification	  of	  the	  retroperitoneal	  space	  by	  the	  lifting	  of	  the	  peritoneum	  and	  the	  
subsequent	  high	  dissection	  of	  the	  vessels	   is	  crucial	   for	  achieving	  sufficient	   length	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for	  the	  intraabdominal	  testes	  without	  dividing	  the	  vessels	  thus	  avoiding	  a	  Fowler-­‐
Stephens	  procedure.	  	  
	  
Fowler-­‐Stephens	  procedure	  
If	  sufficient	  length	  could	  not	  be	  achieved	  after	  extensive	  retroperitoneal	  dissection	  
a	   single-­‐step	   open	   Fowler-­‐Stephens	   procedure	   was	   performed	   by	   dividing	   the	  
spermatic	  vessels	  proximally	  in	  most	  cases.	  	  
	  
Laparoscopic	  procedure	  
In	   all	   boys	   with	   non-­‐palpable	   testes	   an	   initial	   diagnostic	   laparoscopy	   was	  
performed.	  After	  an	  umbilical	   incision	  according	  to	  Hasson	  a	   trocar	  was	   inserted	  
and	  carbon	  dioxide	  was	  insufflated	  with	  a	  pressure	  of	  10	  mm	  Hg	  and	  a	  low	  rate	  of	  
1	   l/minute.	  After	  completed	   insufflation	  a	  0	  or	  30	  degree	  5	  mm	  laparoscope	  was	  
inserted,	   if	   required	   additional	  working	   trocars	  were	   inserted.	   The	   position	   and	  
size	   of	   the	   testis,	   the	   internal	   rings,	   contralateral	   side	   and	   abnormalities	   were	  
described.	  The	  next	  surgical	  step	  was	  decided	  upon	  after	  assessment	  of	  the	  intra-­‐
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5.2	  	  	  Testicular	  biopsies	  
A	  total	  of	  213	  biopsies	  collected	   from	  215	  boys	  biopsies	  were	  analyzed.	  An	  open	  
wedge	  of	  tissue	  approximately	  1x2	  mm	  in	  size	  was	  removed	  from	  the	  undescended	  
testis	  after	  incision	  of	  the	  capsule.	  In	  most	  cases	  the	  biopsy	  was	  taken	  with	  a	  pair	  of	  
scissors	  however	  if	  the	  testicular	  tissue	  was	  not	  “bulging”	  as	  seen	  in	  atrophic	  testes	  
forceps	  were	  used.	  The	  capsule	  was	  closed	  with	  a	  6:0	  resorbable	  suture	  after	  the	  
biopsy	  was	  taken.	  	  
	  
For	   microscopy	   the	   biopsies	   were	   fixed	   by	   immersion	   in	   5%	   glutaraldehyde	  
dissolved	  in	  s-­‐collidine	  buffer	  (0.16	  M,	  pH	  7.4)	  at	  room	  temperature	  as	  described	  
earlier	   [140].	  Thereafter,	   the	   tissues	  were	  embedded	   in	  epoxy	  resin	   (Glycidether	  
100,	   Merck,	   Germany),	   cut	   into	   semi-­‐thin	   (1-­‐μm)	   sections	   and	   stained	   with	  
toluidine	  blue	  and	  periodic	  acid-­‐Schiff	  (PAS)	  staining	  (PAS-­‐kit	  1016460001,	  Merck,	  
Germany).	   In	   each	   round	   cross-­‐section	   of	   the	   seminiferous	   cord,	   cells	   exhibiting	  
nuclear	  morphology	  typical	  of	  germ	  cell	  as	  well	  as	  Sertoli	  cells	  were	  counted.	  The	  
cord	   diameter	   and	   the	   proportion	   of	   the	   testis	   made	   up	   by	   the	   interstitial	  
compartment	   were	   determined	   with	   a	   morphometric	   program	   (Leica	   IM500	  
Version:	  4.0,	  Leica	  Microsystems	  Imaging	  Solutions	  Ltd.,	  Cambridge,	  UK).	  
	  
	  
5.3	  	  	  Testicular	  volume	  
The	   testicular	   volume	   of	   the	   retained	   and	   scrotal	   testes	   was	   determined	   with	  
ultrasound	  measurements	  at	  the	  ages	  of	  0-­‐3	  weeks,	  6	  months,	  and	  yearly	  up	  to	  5	  
years	  of	  age,	  performed	  by	  radiologists.	  	  
	  
Two	   formulas	   for	   a	   prolapsed	   ellipsoid	   have	   been	   used,	   one	   for	   the	   ultrasound	  
measurements	   and	   another	   formula	   for	   the	   ruler	  measurements.	   The	   reason	   for	  
this	   is	   that	   the	   radiologist	   in	   study	   I-­‐III	   used	   a	  different	   formula	   to	   calculate	   the	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testicular	  volume	  than	  the	  one	  used	  for	  the	  ruler	  measurements;	  in	  spite	  of	  this	  fact	  
both	  formulas	  yield	  the	  same	  results.	  	  	  
	  
The	   ultrasound	   examinations	   were	   performed	   using	   high-­‐resolution	   scanners.	  
Testicular	   volumes	   were	   calculated	   using	   the	   approximation	   for	   a	   prolapsed	  
ellipsoid:	   V	   =	   π/6	   x	   L	   (length)	   x	   W	   (width)	   x	   H	   (height).	   One	   experienced	  
radiologist	  performed	  the	  majority	  of	  ultrasound	  procedures	  (UH).	  All	  examiners	  
were	  blinded	  for	  previous	  results	  and	  preliminary	  data.	  However,	  scars	  following	  
the	  orchidopexies	  were	  obvious	  in	  most	  cases.	  	  
	  
The	   measurements	   taken	   at	   time	   of	   surgery	   were	   done	   using	   a	   ruler	   and	   the	  
volume	   was	   calculated	   using	   the	   following	   formula:	   V	   =	   4/3*π*a*b*c.	   where	  
Π=3.14,	   and	   a,	   b,	   c	   are	   the	   semi-­‐axes	   of	   an	   ellipsoid.	   The	   testicular	   volume	  was	  
assessed	   prior	   to	   the	   biopsy.	   The	   same	   pediatric	   surgeon	   (CK)	   performed	  more	  
than	  95	  %	  of	  all	  the	  ruler	  measurements.	  	  
	  
	  
5.4	  	  	  Hormonal	  assays	  
FSH	  and	  LH	  assays	  
Serum	   FSH	   and	   LH	   were	   measured	   in	   singlicate	   with	   commercially	   available	  
reagents	  from	  Perkin	  Elmer/Wallac	  (article-­‐nr	  B017-­‐201)	  on	  a	  1235	  AutoDELFIA	  
immunoassay	  system.	  For	  more	  details	  on	  the	  methodology	  see	  original	  paper	  IV.	  	  
	  
Inhibin	  B	  assay	  
Inhibin	   B	   was	   measured	   in	   duplicate	   in	   serum	   with,	   at	   the	   time,	   commercially	  
available	   ELISA-­‐reagents	   from	   Oxford	   Bio-­‐Innovation.	   For	   more	   details	   on	   the	  





Testosterone	   was	   measured	   in	   duplicate	   in	   serum	   with	   commercially	   available	  
reagents	   from	   Orion	   Diagnostica	   as	   modified	   and	   optimized	   according	   to	  
Ankarberg	  and	  Norjavaara	  [142].	  	  
	  
	  
5.5	  	  	  Statistical	  methods	  
All	  used	  methods	  and	  analyzes	  were	  done	  by	  statisticians	  and	  described	   in	  more	  

















6.1	  	  	  Study	  I	  
Testicular	   volume	   was	   determined	   with	   ultrasound	   measurements	   at	   ages	   0-­‐3	  
weeks,	  6	  months,	  1	  and	  2	  years	  of	  age	  obtained	  from	  boys	  with	  palpable	  unilateral	  
cryptorchidism	  randomized	  to	  surgery	  at	  9	  months	  (n=70)	  or	  at	  3	  years	  (n=79)	  of	  
age.	  
	  
Development	  of	  the	  scrotal	  testes	  from	  birth	  up	  to	  two	  years	  of	  age	  (Fig.	  8)	  
Between	  0-­‐3	  weeks	  and	  6	  months	  of	  age	  the	  normally	  descended	  testis	  increased	  
significantly	  in	  median	  volume	  (p<0.001),	  whereas	  from	  6	  to	  24	  month	  there	  was	  
















Fig. 8. Development of testicular volume of the scrotal testes in boys with palpable 
unilaterally undescended testes. At 6 months of age all boys were randomised to 
orchidopexy at 9 months (n=70) or 3 years (n=79). The number of performed 
ultrasonographies is shown in the figure (Medians and 95% confidence intervals).	  
	  
	  
Development	  of	  the	  retained	  testes	  from	  birth	  to	  two	  years	  of	  age	  (Fig.	  9	  &	  10)	  
Between	  0-­‐3	  weeks	  and	  6	  months	  of	  age	  the	  retained	  testes	   increased	  in	  median	  
volume	  (p<0.001).	  At	  both	  1	  and	  2	  years	  of	  age	  there	  was	  a	  significant	  difference	  in	  
median	  volume	  between	  the	  treated	  and	  the	  non-­‐treated	  group	  (p<0.01,	  p<0.001	  








Fig. 9 Development of testicular volume of the retained testes in boys with palpable 
unilaterally undescended testes from age 0-3 week to 2 years. At 6 months of age all 
boys were randomised to orchidopexy at 9 months (n=70) or at 3 years (n=79). The 
number of performed ultrasonographies is shown in the figure (Medians and 95% 
confidence intervals).  
	  
The	   ratio	   between	   the	   scrotal	   and	   retained	   testes	   provides	   a	   comparison	   of	   the	  
degree	   of	   growth	   deficit	   in	   the	   retained	   testes.	   In	   the	   treated	   group	   the	  median	  
ratio	  increased	  from	  6	  months	  to	  2	  years	  (p<0.01)	  whereas	  in	  the	  untreated	  group	  
the	   ratio	   decreased.	   Furthermore	   at	   age	   2	   years	   there	  was	   a	   difference	   in	   ratio	  











Fig. 10. Development of the ratio between the retained and scrotal testes. At 6 months 
of age all boys were randomised to orchidopexy at 9 months (n=70) or 3 years (n=79). 




Interestingly	  already	  at	  birth	  there	  was	  a	  significant	  difference	  in	  median	  volume	  
between	   the	   retained	   and	   scrotal	   testes.	   In	   order	   to	   investigate	   what	   effect	   the	  
suprascrotal	  position	  had	  on	  the	  retained	  testes	  we	  extrapolated	  a	  group	  of	  boys	  
(n=22)	   that	  had	  almost	  equal	   size	  of	   the	   retained	   testes	   compared	   to	   the	   scrotal	  
testes	  at	  birth.	  Results	  showed	  that	  at	  6	  months	  the	  retained	  testes	  had	  grown	  less	  
than	   the	   scrotal	   ones	   (p<0.001),	   clearly	   indicating	   that	   the	   suprascrotal	   position	  





6.1.1	  	  	  Conclusion	  
Surgical	  treatment	  at	  9	  months	  of	  age	  resulted	  in	  a	  significant	  catch-­‐up	  testicular	  
growth	   from	   6	  months	   to	   2	   years	   compared	   to	   non-­‐treatment.	   Furthermore	  we	  
have	  demonstrated	  that	  prenatal	  factors	  play	  a	  role	  for	  testicular	  volume	  at	  birth	  




6.2	  	  	  Study	  II	  
This	  study	  is	  a	  follow-­‐up	  from	  study	  I	  where	  surgical	  treatment	  at	  9	  months	  were	  
compared	   to	   non-­‐treatment	   up	   to	   2	   years	   of	   age.	   In	   this	   study	  we	   continued	   to	  
analyze	   the	   testicular	   volume	   up	   to	   4	   years	   of	   age	   from	   boys	   with	   palpable	  
unilateral	  cryptorchidism	  randomized	  to	  surgery	  at	  9	  months	  (n=72)	  or	  at	  3	  years	  
(n=83).	  	  
	  
Development	  of	  the	  scrotal	  testes	  from	  birth	  up	  to	  four	  years	  of	  age	  (Fig.	  11)	  
In	  accordance	  with	  results	   from	  study	  I	   the	  scrotal	  testes	  grew	  significantly	  from	  
birth	  to	  6	  months	  of	  age,	  with	  no	  subsequent	  growth	  up	  to	  two	  years,	  however	  a	  
growth	  from	  6	  months	  to	  4	  years	  was	  demonstrated	  (p<0.001),	  no	  difference	  was	  
observed	  in	  testicular	  volume	  of	  the	  scrotal	  testes	  between	  the	  randomized	  groups	  










Fig. 11. Development of testicular volume of the scrotal testes in boys from age 0-3 
week to 4 years. At 6 months of age all boys were randomised to orchidopexy at 9 
months (n=72) or at 3 years (n=83). The numbers of testes examined are shown in the 
figure. (Medians and 95% confidence intervals). 
	  
	  
Development	  of	  the	  retained	  testes	  from	  birth	  to	  four	  years	  of	  age	  (Fig.	  12	  &	  13)	  
The	  retained	  testes	  grew	  significantly	  from	  birth	  to	  6	  months	  of	  age,	  furthermore	  
there	   were	   significant	   differences	   between	   the	   scrotal	   and	   previously	   retained	  
testes	  at	  all	  ages	  (p<0.001)	  up	  to	  4	  years	  of	  age	  in	  both	  groups.	  	  
	  
Surgical	  treatment	  at	  9	  months	  resulted	  in	  a	  significant	  growth	  (p<0.001)	  from	  6	  
months	  to	  2,	  3	  and	  4	  years	  of	  age	  whereas	  in	  the	  group	  treated	  at	  3	  years	  there	  was	  
no	  significant	  growth	  before	  and	  after	  orchidopexy.	  	  
	  60	  
	  
In	  the	  group	  that	  underwent	  surgery	  at	  9	  months	  there	  was	  an	  increase	  in	  the	  ratio	  
from	  6	  months	   to	   4	   years	   (p<0.001)	  whereas	   a	   decrease	   in	   the	   ratio	   during	   the	  
same	   period	   was	   observed	   in	   the	   group	   that	   was	   treated	   at	   3	   years	   (p<0.001).	  
There	  was	  a	  significant	  difference	  in	  testicular	  volume	  and	  ratios	  at	  ages	  2,	  3	  and	  4	  




Fig.12. Development of testicular volume of the initially retained testes in boys from 
age 0-3 weeks to 4 years. At 6 months of age all boys were randomised to 
orchidopexy at 9 months (n=72) or at 3 years (n=83). The number of testes examined 











Fig .13. Development of the ratio between the retained and scrotal testes in boys from 
age 0-3 weeks to 2 years. At 6 months of age all boys were randomised to 
orchidopexy at 9 months (n=72) or 3 years (n=83). The numbers of performed 
ultrasonographies are shown in the figure (Medians and 95% confidence intervals). 
	  
6.2.1	  	  	  Conclusion	  
We	   have	   shown	   that	   the	   partial	   catch-­‐up	   growth	   of	   initially	   retained	   testes	  
continued	  up	  to	  4	  years	  in	  boys	  who	  were	  operated	  on	  at	  9	  months.	  However,	  the	  
testicular	  volumes	  were	  still	  not	  equal	  to	  their	  scrotal	  counterparts.	  On	  the	  other	  
hand,	  in	  the	  group	  treated	  later	  the	  testes	  showed	  a	  decrease	  in	  growth	  compared	  
to	   their	  scrotal	  counterparts	  and	  a	  significant	  difference	   in	   testicular	  volume	  and	  







6.3	  	  	  Study	  III	  
Volumetric	  data	  from	  birth	  up	  to	  5	  years	  of	  age	  were	  obtained	  from	  71	  boys	  with	  
spontaneous	   descent	   that	   at	   birth	   had	   palpable	   unilaterally	   cryptorchid	   testes.	  
These	   boys	   were	   compared	   to	   boys	   that	   were	   still	   unilaterally	   cryptorchid	   and	  
randomized	  to	  surgery	  at	  either	  9	  months	  (n=78)	  or	  3	  years	  (n=85)	  of	  age.	  	  
	  
Age	  at	  spontaneous	  descent	  and	  ascending	  testes	  
91	   boys	   showed	   spontaneous	   descent	   after	   being	   initially	   cryptorchid,	   71	   testes	  
remained	  descended	  whereas	  20	  ascended	  to	  a	  cryptorchid	  position	  (22	  %).	  Result	  
showed	  that	  spontaneous	  descent	  occurred	  mainly	  before	  2	  months	  of	  age	  (82	  %).	  
The	  recurrences	  occurred	  evenly	  distributed	  between	  1	  and	  5	  years	  of	  age.	  	  
	  
Growth	   of	   the	   spontaneously	   descended	   testes	   compared	   to	   surgically	   treated	  
testes	  and	  their	  scrotal	  counterparts	  (Fig.	  14)	  
The	  testicular	  volume	  of	  the	  scrotal	  testes	  did	  not	  differ	  between	  any	  of	  the	  groups	  
at	  any	  time	  point.	  	  	  
	  
At	  inclusion	  age	  0-­‐3	  weeks	  the	  volume	  of	  the	  retained	  or	  the	  spontaneously	  
descended	  did	  not	  significantly	  differ	  between	  any	  of	  the	  groups,	  although	  at	  6	  
months	  the	  group	  with	  spontaneous	  descent	  showed	  the	  highest	  mean	  volume	  
compared	  to	  the	  yet	  non-­‐treated	  groups.	  	  	  
	  
In	  study	  I	  and	  II	  we	  concluded	  that	  the	  surgically	  treated	  testes	  were	  significantly	  
larger	  than	  their	  scrotal	  counterparts	  at	  all	  ages	  up	  to	  4	  years	  of	  age,	  this	  study	  has	  
demonstrated	  that	  the	  difference	  still	  persists	  up	  to	  5	  years	  of	  age,	  also	  showed	  for	  
the	  spontaneously	  descended	  testes	  compared	  to	  their	  scrotal	  counterparts	  at	  all	  




In	  study	  II	  we	  demonstrated	  that	  the	  retained	  testes	  between	  the	  early	  and	  late	  
treated	  group	  showed	  significant	  differences	  in	  testicular	  volume	  up	  to	  4	  years	  of	  
age,	  in	  this	  study	  we	  conclude	  that	  the	  significant	  difference	  still	  persists	  up	  to	  5	  
years	  of	  age	  (p<0.023).	  	  
	  
When	  comparing	  the	  spontaneously	  retained	  testes	  to	  the	  surgically	  treated	  testes	  
we	  observed	  no	  difference	  between	  the	  spontaneously	  descended	  testes	  and	  the	  
ones	  treated	  at	  9	  months,	  however	  when	  compared	  to	  testes	  treated	  at	  3	  years	  the	  
spontaneously	  descended	  testes	  were	  larger	  at	  all	  ages	  (except	  at	  0-­‐3	  weeks),	  with	  
significant	  differences	  at	  ages	  2,	  4	  and	  5	  years.	  	  
	  
Figure 14. Cross sectional data: The testicular volumes of the retained (open circles) 
and scrotal (filled circles) testes from birth until 5 years of age. From left to right: early 
treated group (9 month), late treated group (3 years) and the spontaneously 





Comparing	  the	  ratios	  between	  the	  three	  groups	  from	  birth	  to	  5	  years	  of	  age	  (Fig.	  
15)	  
The	  ratio	  provides	  a	  direct	  comparison	  of	  growth	  between	  the	  retained	  and	  scrotal	  
testis	  and	  thus	  an	  index	  of	  the	  degree	  of	  growth	  deficit	  of	  the	  retained	  or	  initially	  
retained	  testes.	  
	  
The	  group	  surgically	  treated	  at	  9	  months	  showed	  an	  increased	  ratio	  from	  6	  months	  
to	  5	  years	  (p<0.013),	  whereas	  the	  group	  treated	  at	  3	  years	  decreased	  its	  ratio	  over	  
the	  study	  period,	  however	  not	  significant.	  Interestingly	  the	  group	  with	  
spontaneous	  descent	  also	  showed	  a	  decreasing	  ratio	  over	  the	  study	  period	  
(p<0.021).	  	  
	  
When	  comparing	  groups,	  there	  was	  a	  significant	  difference	  in	  the	  ratio	  over	  the	  
study	  period	  between	  the	  early	  treated	  (9	  months)	  and	  late	  treated	  (3	  years)	  group	  





Fig. 15. Cross sectional data: The ratios between the previously retained testes and its 
scrotal counterpart (%) from birth until 5 years of age are shown. From left to right: 
early treated group (9 months), late treated group (3 years) and the spontaneously 
descended group. Mean and 95 % confidence intervals are shown. 
	  
	  
6.3.1	  	  	  Conclusion	  
We	  have	  demonstrated	   that	  spontaneously	  descended	  testes	  show	  a	  significantly	  
impaired	   growth	   from	   birth	   up	   to	   5	   years	   of	   age	   compared	   to	   their	   scrotal	  
counterparts	  and	   that	   they	  also	  are	  more	  prone	   to	   subsequent	  ascent	   (recurrent	  
undescended	   testes).	   Orchidopexy	   at	   9	   months	   of	   age	   improved	   the	   testicular	  
growth	  up	  to	  5	  years	  compared	  to	  those	  treated	  at	  3	  years,	  although	  these	  testes	  
did	  not	   fully	   reach	   the	  growth	   rate	  of	   the	   scrotal	   testes	   in	  any	  group.	  Also,	   early	  
surgery	  improved	  testicular	  growth	  of	  the	  previously	  retained	  testes	  up	  to	  5	  years	  
compared	   to	   their	   scrotal	   counterparts	   (ratio).	   In	   addition,	   the	   growth	   was	  
significantly	  higher	   than	   in	   the	  group	   treated	   later	  and,	   interestingly,	   than	   in	   the	  
	  66	  
	  
group	  with	   spontaneous	   descent.	   The	   smallest	   testes	  were	   the	   ones	   treated	   late	  
whereas	  there	  was	  no	  significant	  difference	  in	  testicular	  volume	  between	  the	  testes	  
operated	   on	   at	   9	  months	   compared	   to	   the	   spontaneously	   descended	   ones.	   Over	  
time,	   however,	   the	   spontaneously	   descended	   testes	   grew	   less	   (decreased	   ratio)	  
compared	  to	  the	  testes	  treated	  at	  9	  months.	  	  
	  
6.4	  	  	  Study	  IV	  
Morphometric	   (biopsies)	   and	   volumetric	   data	   (ruler	   measurements)	   were	  
collected	   from	  boys	  with	   palpable	   unilateral,	   bilateral	   and	   intraabdominal	   testes	  
surgically	  treated	  at	  9	  months	  or	  3	  years	  of	  age.	  	  
	  
Blood	   samples	   for	   analysis	   of	   inhibin	   B	   and	   FSH	   were	   collected	   from	   boys	  with	  
unilateral	  or	  bilateral	  cryptorchidism	  before	  and	  after	  surgical	  treatment	  and	  from	  
boys	  with	  spontaneous	  descent	  at	  ages	  0-­‐3	  weeks,	  2	  and	  6	  months,	  1,	  2	  and	  4	  years.	  
Testosterone	  and	  LH	  levels	  are	  reported	  for	  ages	  0-­‐3	  weeks,	  2	  and	  6	  months	  only,	  
since	  blood	  levels	  at	  subsequent	  ages	  were	  very	  low	  and	  often	  not	  measurable.	  To	  
investigate	  the	  relationship	  between	  inhibin	  B	  and	  FSH	  all	  measurements	  from	  all	  
groups	  were	  added	  together	  at	  all	  time	  points.	  
	  
Morphometric	  and	  volumetric	  results	  (Table	  5)	  	  	  
All	   testes	   treated	   at	   9	  months	   showed	   significantly	  more	   germ	   and	   Sertoli	   cells	  
100/cords,	  greater	  testicular	  volume,	  greater	  diameter	  of	  seminiferous	  tubules	  and	  
less	  interstitial	  tissue	  when	  compared	  to	  those	  treated	  at	  3	  years	  (p<0.001).	  	  
	  
When	   comparing	   the	   early	   (9	  months)	   treated	   palpable	   unilateral,	   bilateral	   and	  
intraabdominal	   groups	   to	   each	   other	   the	   only	   observed	   significance	   was	   in	   the	  




At	   3	   years	   the	   same	   correlations	   showed	   that	   the	   only	   observed	   significance	  
(borderline)	  was	  in	  the	  number	  of	  germ	  cells	  between	  the	  palpable	  unilateral	  and	  
intraabdominal	  group,	   thus	   indicating	   that	   the	   late	   treated	   intraabdominal	   testes	  
showed	  the	  worst	  germ	  cell	  depletion	  of	  all	  groups	  (both	  early	  and	  late	  groups).	  	  
	  
Correlation	  between	  testicular	  volumes	  and	  the	  number	  of	  germ	  and	  Sertoli	  
cells/100	  cords	  were	  evaluated	  for	  all	  the	  cryptorchid	  boys	  lumped	  together	  and	  
the	  testicular	  volume	  at	  surgery	  correlated	  significantly	  to	  the	  number	  of	  both	  
germ	  and	  Sertoli	  cells	  (p<0.001).	  	  
	  
At	  9	  months	  the	  same	  significant	  correlations	  were	  found	  for	  germ	  and	  Sertoli	  
cells	  (p<0.001	  and	  p<0.01	  respectively),	  but	  at	  3	  years,	  the	  correlation	  was	  
significant	  (p<0.05)	  for	  Sertoli	  cells	  only,	  however	  at	  3	  years	  there	  were	  very	  few	  


















Table 5: Testicular volume (Vol. (cm3)), cord diameters (Diam. (µm)), percentage of 
interstitial tissue (Int. Tissue (%)) as well as counted numbers of Sertoli cells per 100 
seminiferous cords (SC/ 100 sc (n)) and germ cells per 100 seminiferous cords (GC/ 
100 sc (n)) were counted and are listed for unilateral, bilateral and intraabdominal 
cases (G). Number of samples (n) for cord diameter, percentages of interstitial tissue, 
Sertoli cells and germ cells per 100 seminiferous cords are given in the first column, 




Cross	  sectional	  pictures	  are	  shown	  to	  illustrate	  the	  morphometric	  findings	  in	  
palpable	   and	   non-­‐palpable	   testes	   from	   boys	   treated	   at	   9	  months	   and	   at	   3	  





Fig.16. Testicular histology of cryptorchid testes. Cross sections the seminiferous 
cords from 9 month (A, C and E) and 3 year (B, D and F) old patients are shown after 
PAS staining. Areas shown with a higher magnification are marked with a square (A-F) 
and are depicted on the left and right side of the panel (a-f). Germ cells with normal 
nuclei (white arrowheads) as well as multi-nuclei (black arrowheads) were observed in 
unilateral (A and B), bilateral (C and D) testicular biopsies from 9 month and three year 
old patients, as well as intra-abdominal cases of 9 month old patients. Only few germ 

















Fig. 17: Cross sections of cryptorchid testes taken with light microscopy. A, early 
unilateral; B, late intra-abdominal. Germ cells (white arrowheads: gonocytes and 
spermatogonia) are shown in 9 month old testis (A), but are nearly fully depleted in 3 







Figure 18: Cross sections of cryptorchid testes taken with transmission electron 
microscopy (TEM). A, early unilateral; B, late unilateral; C, early intra-abdominal; D, 
late intra-abdominal. SC, Sertoli cells; G, gonocytes. BM, basal membrane; PC, 
peritubular cell; SC, Sertoli cell; SPG, spermatogonia  
	  
	  
Hormonal	  results	  (Fig.	  19	  a-­‐e)	  	  
All	  analyzed	  hormones	  showed	  a	  peak	  in	  serum	  levels	  during	  the	  first	  two	  months	  
of	  life,	  thereafter	  decreasing	  to	  lower	  levels	  throughout	  the	  study	  periods.	  LH	  and	  
testosterone	  did	  not	  differ	  between	  any	  of	  the	  groups	  at	  any	  of	  the	  time	  points	  (Fig.	  
19	  c-­‐d).	  	  
	  72	  
	  
At	  age	  2	  months	  the	  group	  with	  bilateral	  cryptorchidism	  showed	  higher	  inhibin	  B	  
serum	  levels	  than	  the	  groups	  with	  spontaneous	  descent	  and	  the	  boys	  that	  were	  still	  
cryptorchid	  (p<0.001	  and	  p<0.008	  respectively),	  however	  at	  age	  4	  years	  the	  group	  
with	   spontaneous	   descent	   showed	   higher	   inhibin	   B	   levels	   than	   the	   previously	  
cryptorchid	  boys	  (p<0.008).	  Overall	  FSH	  and	  inhibin	  B	  levels	  decreased	  over	  time	  
in	  a	  similar	  fashion	  (Fig.	  19	  e).	  	  
	  
At	  2	  years	  of	  age,	  the	  boys	  that	  had	  been	  operated	  on	  at	  9	  months	  had	  significantly	  
lower	  FSH	  levels	  than	  those	  that	  had	  not	  yet	  been	  treated,	  and	  also	  higher	  inhibin	  B	  
values,	  however	  not	  significant	  (fig	  19	  a-­‐b).	  	  Furthermore,	  neither	  of	  the	  hormones	  
analyzed	  at	  0-­‐3	  weeks	  or	  2	  months	  could	  predict	  spontaneous	  descent.	  	  
	  
Correlations	  morphology,	  testicular	  volume	  and	  hormones	  
Correlations	  between	  inhibin	  B	  levels	  at	  6	  months	  and	  at	  4	  years	  (before	  and	  
after	  orchidopexy)	  and	  testicular	  volume	  were	  also	  investigated.	  For	  the	  boys	  
with	  unilateral	  cryptorchidism	  inhibin	  B	  values	  at	  both	  6	  months	  and	  4	  years	  
correlated	  positively	  with	  testicular	  volume	  of	  the	  retained	  testes	  at	  4	  years	  
(p<0.005	  and	  p<0.0014	  respectively).	  On	  the	  contrary	  boys	  with	  bilaterally	  
undescended	  testes,	  testicular	  volume	  at	  6	  months	  correlated	  negatively	  with	  
inhibin	  B	  values	  at	  4	  years,	  i.e.	  boys	  with	  small	  testes	  had	  high	  inhibin	  B	  values	  at	  
4	  years.	  	  
	  
Furthermore	  correlations	  between	  hormones	  taken	  at	  2	  months	  and	  the	  number	  
of	   germ	   and	   Sertoli	   cells	   were	   investigated	   to	   assess	   whether	   any	   of	   the	  
hormones	   taken	   during	   minipuberty	   can	   predict	   future	   spermatogenesis.	   The	  
only	  positive	  correlation	  found	  was	  between	  inhibin	  B	  values	  at	  2	  months	  for	  the	  
boys	  with	  unilaterally	  palpable	  testes	  with	  the	  number	  of	  Sertoli	  cells	  at	  9	  months	  
(p<0.001)	  but	  not	   at	  3	   years.	  No	  other	   correlations	  were	   identified	   between	  




Fig. 19 a-e. Hormone levels for the different patient groups (spontaneous descent, 
preoperative unilateral, postoperative unilateral and bilateral groups). Inhibin B and 
FSH was measured at ages 0-3 weeks, 2, 6, 12, 24 and 48 months (a-b) and LH and 
testosterone was measured at ages 0-3 weeks, 2 and 6 months (b-c). Inhibin and FSH 




6.4.1	  	  	  Conclusion	  
The	  morphometric	   data	   show	   that	   at	   9	  months,	   the	   undescended	   testes	   have	   a	  
significantly	   larger	   number	   of	   germ	   and	   Sertoli	   cells,	   greater	   diameter	   of	  
seminiferous	  tubules	  and	  a	  higher	  ratio	  interstitial/tubular	  tissue	  than	  at	  3	  years	  
of	  age.	  Furthermore,	  at	  3	  years	  of	  age	  the	  intraabdominal	  testes	  showed	  the	  worst	  
depletion	  of	  germ	  cells,	  clearly	  indicating	  that	  the	  longer	  the	  testes	  reside	  in	  this	  
position	  the	  higher	  risk	  for	  impaired	  spermatogenesis.	  	  
	  
The	   above	   mentioned	   morphometric	   data	   are	   in	   concordance	   with	   previously	  
published	  volumetric	  studies	  (study	  I	  and	  II),	  thus	  suggesting	  that	  early	  surgery	  is	  
beneficial	  for	  spermatogenesis	  and	  giving	  further	  support	  for	  early	  orchidopexy.	  	  
	  
Furthermore	   we	   have	   in	   this	   study	   proved	   that	   ultrasound	   measurements	   of	  
testicular	  volume	  correlate	  with	  ruler	  measurements	  at	  the	  time	  of	  orchidopexy	  
and	  that	  the	  ruler	  measurements	  significantly	  correlate	  with	  the	  number	  of	  germ	  
and	   Sertoli	   cells.	   To	   our	   knowledge	   this	   has	   never	   been	   proven	   in	   cryptorchid	  
boys	  prior	  to	  this	  study,	  but	  it	  clearly	  indicates	  that	  testicular	  volume	  can	  be	  used	  
as	  a	  proxy	  for	  testicular	  function	  in	  cryptorchid	  boys.	  	  
	  
Serum	  levels	  of	  hormones	  reflect	  the	  output	  of	  both	  testes	  and	  are	  therefore	  not	  
easily	   interpreted	   in	   unilateral	   cryptorchidism,	  which	   account	   for	   a	  majority	   of	  
the	   cryptorchid	   boys.	   However,	   inhibin	   B	   may	   be	   of	   interest	   in	   bilateral	  
cryptorchidism,	  where	  one	  would	  expect	  lower	  values,	  reflecting	  poor	  Sertoli	  cell	  
function.	   As	   discussed	   before	   in	   the	   section	   on	   fertility	   inhibin	   B	  may	   possibly	  
serve	  as	  a	  marker	   for	  compromised	  paternity	   in	  men	  with	  a	  history	  of	  bilateral	  
cryptorchidism,	   whereas	   for	   cryptorchid	   boys	   the	   results	   are	   contradictive.	  
Therefore	   the	   predictive	   value	   of	   prepubertal	   inhibin	   B	   for	   the	   quality	   of	  




In	  our	  study	  we	  surprisingly	  found	  that	  the	  levels	  of	  inhibin	  B	  during	  minipuberty	  
were	  actually	   the	  highest	   in	  the	  bilateral	  group	  compared	  to	  unilateral	  cases	  and	  
boys	  with	  spontaneous	  descent	  (presumably	  the	  most	  normal	  testes).	  In	  addition	  
FSH	  levels	  were	  high	  in	  the	  bilateral	  cases	  at	  this	  age.	  This	  was	  reversed	  at	  the	  age	  
of	   four	  when	   the	   group	  with	   spontaneous	   descent	   showed	   higher	   inhibin	   B	   and	  
FSH	   levels	   than	   the	   previously	   cryptorchid	   boys.	  We	   find	   it	   difficult	   to	   interpret	  
these	  data	  and	  therefore	  no	  conclusions	  can	  be	  drawn.	  	  
	  
Furthermore	  we	  have	  shown	  that	   inhibin	  B	  correlated	  positively	  with	  FSH	   levels	  
throughout	  the	  study	  period.	  We	  have	  also	  demonstrated	  that	  boys	  with	  unilateral	  
cryptorchidism	  and	  high	  levels	  of	  inhibin	  B	  at	  6	  months	  and	  4	  years	  also	  had	  bigger	  
testes	  at	  4	  years	  than	  boys	  with	  low	  levels,	  thus	  indicating	  that	  inhibin	  B	  taken	  at	  6	  
months	  can	  be	  used	  as	  a	  marker	  for	  testicular	  growth.	  However,	  we	  have	  not	  been	  
able	  to	  show	  the	  same	  in	  bilateral	  cases,	  so	  the	  results	  are	  inconclusive	  and	  remain	  
highly	  speculative.	  	  	  
	  
In	  summary,	  we	  have	  not	  been	  able	  to	  show	  that	  any	  of	  the	  hormones	  taken	  during	  
the	   first	   months	   of	   life	   can	   serve	   as	   a	   marker	   for	   future	   spermatogenesis	   or	   to	  
predict	  spontaneous	  descent	  of	  the	  testes.	  	  
	  
6.5	  	  	  Surgical	  results	  	  
Success	  rate	  by	  position	  and	  age	  
Success	  rates	  for	  palpable	  uni-­‐	  and	  bilateral	  cases	  treated	  at	  9	  months	  and	  3	  years	  
were	  95	  %	  (5	  atrophies/109	  procedures)	  and	  98	  %	  (2/83)	  respectively,	  with	  an	  
overall	  rate	  of	  96	  %	  (7/192).	  
	  
Success	  rates	  for	  intraabdominal	  testes	  treated	  at	  9	  months	  and	  3	  years	  were	  83	  %	  




Success	   rates	   at	   9	   months	   vs.	   boys	   treated	   at	   3	   years	   (both	   palpable	   and	   non-­‐
palpable	  were	  93	  %	  (9/133)	  and	  98	  %	  (2/95)	  respectively.	  	  
	  
Success	  rate	  by	  procedure	  	  
Success	   rate	   for	   the	   open	   inguinal	   approach	   was	   95	   %	   (11/227).	   Three	   open	  
single-­‐staged	  Fowler-­‐Stephens	  procedures	  were	  performed,	   two	  of	   them	  showed	  
atrophy	  at	  follow-­‐up.	  
	  
Recurrences	  occurred	   in	   three	   cases.	   In	  one	  of	   these	   cases	  an	  orchidectomy	  was	  
done,	  and	  in	  total	  three	  orchidectomies	  were	  undertaken	  in	  the	  study.	  	  
	  
6.5.1	  	  	  Conclusion	  
We	   have	   demonstrated	   that	   the	   open	   inguinal	   approach	   for	   both	   palpable	   and	  
intraabdominal	  testes	  is	  an	  efficient	  (95	  %)	  surgical	  method	  for	  achieving	  scrotal	  
position	  without	  atrophy.	  By	  the	  use	  of	  this	  method	  with	  extensive	  retroperitoneal	  
dissection	  (when	  needed)	  most	  testes	  could	  be	  brought	  down	  to	  scrotum	  without	  a	  
Fowler-­‐Stephens	  procedure	  and	  with	  very	  few	  recurrences.	  	  
	  
To	   our	   knowledge	   there	   are	   no	   previously	   published	   randomized	   studies	   on	  
success	   rate	   correlated	   with	   the	   age	   at	   orchidopexy.	   In	   our	   series	   the	   overall	  
success	  rate	  of	  orchidopexy	  for	  all	  testes	  (both	  palpable	  and	  intraabdominal)	  at	  9	  






7.	  Discussion	  	  
Cryptorchidism	   is	   the	   most	   common	   anomaly	   in	   newborn	   boys	   [3].	   Despite	   its	  
frequency	   there	   are	   many	   controversies	   regarding	   several	   aspects,	   including	  
aetiology,	   mode	   and	   timing	   of	   treatment	   as	   well	   as	   the	   risk	   of	   infertility	   and	  
testicular	   cancer.	   Almost	   all	   controversies	   are	   the	   result	   of	   a	   lack	   of	   prospective	  
long-­‐term	   studies	   with	   clear	   definitions	   and	   nomenclature;	   consequently	   the	  
numerous	   studies	   very	   often	   include	   a	   mix	   of	   phenotypes	   thus	   showing	  
contradictive	  results.	  Furthermore	  many	  studies	  are	  conducted	  on	  adult	  men	  with	  
a	   history	   of	   cryptorchidism	   whereas	   others	   are	   conducted	   on	   children	   with	   no	  
follow-­‐up	   throughout	   puberty	   and	   into	   adulthood.	   Decades	   ago,	   treatment	   was	  
generally	   given	   at	   a	   higher	   age	   than	   is	   currently	   recommended,	  which	  makes	   it	  
very	   difficult	   to	   assess,	   on	   the	   basis	   of	   published	   studies,	   whether	   surgery	   in	  
infancy	  improves	  spermatogenesis.	  	  
	  
The	   main	   objectives	   of	   this	   thesis	   report	   are:	   to	   present	   the	   first	   prospective	  
randomized	   study	   on	   the	   timing	   of	   treatment,	   to	   identify	   markers	   of	   testicular	  
function	  important	  to	  future	  spermatogenesis,	  and	  to	  study	  the	  growth	  and	  natural	  
course	  of	  spontaneously	  descended	  testes.	  	  
	  
In	   our	   studies	   we	   diagnose	   undescended	   testes	   by	   using	   a	   clear	   definition	   and	  
nomenclature	   for	   the	   different	   forms	   of	   cryptorchidism,	   which	   have	   resulted	   in	  
several	   (nine)	   subgroups	   of	   cryptorchid	   boys	   including	   a	   mixed	   group	   with	  
inhomogeneous	   phenotypes.	   In	   addition,	   we	   also	   follow	   boys	   with	   spontaneous	  
descent	   and	   with	   recurrent	   cryptorchidism,	   which	   to	   our	   knowledge	   has	   never	  
before	  been	  done	  prospectively	  from	  birth.	  	  
	  
At	   the	   start	   of	   the	   study	   in	   1998	  boys	  with	   congenital	   undescended	   testes	  were	  
randomized	   to	   surgery	   at	   either	   9	   months	   or	   3	   years	   of	   age.	   In	   2008	   the	  
randomization	  was	  discontinued	  since	  the	  Nordic	  consensus	  group,	  partly	  on	  the	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basis	  of	  our	  published	  volumetric	  studies,	  made	  the	  recommendation	  that	  surgery	  
should	  be	  done	  before	  the	  age	  of	  one	  year	  [20,	  143].	  	  
	  
The	  discontinuation	  of	   the	  randomization	   led	  to	  a	  skewed	  distribution	  of	  boys	   in	  
non-­‐palpable	   and	   bilateral	   cases,	   with	   a	   higher	   number	   of	   boys	   treated	   at	   nine	  
months	  of	  age	  compared	  to	  three	  years	  of	  age.	  Nonetheless	  the	  design	  of	  the	  study	  
and	   number	   of	   boys	   included	   has	   provided	   us	   with	   a	   unique	   opportunity	   to	  
evaluate	   the	   success	   of	   treatment	   at	   different	   ages	   in	   the	   different	   forms	   of	  
cryptorchidism.	  	  
	  
The	  optimal	  timing	  of	  surgery	  has	  long	  been	  debated.	  Based	  on	  indirect	  proof	  from	  
morphological	   studies	   the	  general	   consensus	   is	   that	   treatment	   should	  be	  offered	  
early	   in	  childhood	  [100-­‐102,	  109-­‐111,	  138,	  139].	  However,	   this	   recommendation	  
has	  prior	  to	  our	  study	  not	  been	  proven	  in	  prospective	  randomized	  studies	  where	  
boys	  actually	  have	  been	  randomized	  to	  surgery	  at	  different	  ages	  and	  then	  followed	  
throughout	  puberty	  and	  into	  adulthood.	  	  
	  
Some	  of	  the	  cited	  morphological	  studies	  suggest	  that	  treatment	  in	  early	  infancy	  is	  
beneficial	   compared	   to	   later	   treatment	   but	   since	   they	   are	   retrospective	   there	   is	  
usually	  no	  clear	  definition	  and	  nomenclature	  of	  the	  diagnosis.	  Furthermore,	  other	  
important	  markers	   for	   testicular	   function	   like	   testicular	   size	   and	   serum	   levels	  of	  
hormones	  have	  not	  been	  analyzed	  and	  compared	  to	  the	  morphology	  of	  the	  testis.	  	  
	  
In	   this	   study	   we	   have	   shown	   that	   surgical	   treatment	   at	   nine	   months	   of	   age	   is	  
beneficial	  and	  results	  in	  a	  significant	  difference	  in	  the	  number	  of	  germs	  and	  Sertoli	  
cells,	   greater	   testicular	   volume	   and	   diameter	   of	   the	   seminiferous	   cords	   and	   less	  
interstitial	   tissue	   than	  we	   find	   in	  boys	   treated	  at	   three	  years	  of	   age,	   all	   of	  which	  




Moreover,	  these	  morphometric	  results	  agree	  with	  our	  previously	  published	  studies	  
on	   testicular	  volume.	  They	  clearly	  demonstrate	   that	   testes	  orchidopexied	  at	  nine	  
months	  show	  a	  significant	  partial	  catch-­‐up	  growth	  of	  the	  previously	  retained	  testes	  
up	   to	   five	   years	   of	   age	   compared	   to	   testes	   in	   boys	   treated	   at	   three	   years	   of	   age,	  
where	  no	  such	  catch-­‐up	  growth	  can	  be	  observed	  [143,	  144].	  	  
	  
However,	  one	  can	  argue	  that	  between	  nine	  months	  and	  three	  years	  of	  age	  there	  is	  a	  
decrease	   in	  both	  germ	  and	  Sertoli	  cells	   in	  normal	   testes	  [23,	  109].	  Therefore	  our	  
findings	   with	   a	   decreased	   number	   of	   cells	   do	   not	   prove	   that	   treatment	   at	   nine	  
months	   is	   preferable	   to	   three	   years.	   	  However,	   the	  magnitude	  of	   the	  decrease	   is	  
influenced	  by	  early	  treatment.	  
	  
In	  a	  study	  by	  Paniagua	  et	  al.	  on	  post-­‐mortem	  boys	  it	  was	  shown	  that	  the	  reduction	  
of	  germ	  cells	  for	  boys	  0	  -­‐	  1	  year	  compared	  to	  3	  -­‐	  4	  year	  old	  boys	  was	  approximately	  
5%	  for	  spermatogonia	  and	   for	  Sertoli	  cells	  15%	  [23].	  The	  ages	  at	  orchidopexy	   in	  
our	   study	   are	   fully	   comparable	   to	   the	   post-­‐mortem	   ages	   and	   our	   results	  
demonstrate	  a	  reduction	  between	  nine	  months	  and	  three	  years	  of	  approximately	  
67	  %	  (germ	  cells)	  and	  25	  %	  (Sertoli	  cells)	  respectively,	  thus	  clearly	  indicating	  that	  
cryptorchid	  testes	  suffer	  more	  over	  time	  compared	  to	  normal	  testes.	  	  
	  
As	   discussed	   before,	   studies	   on	   adult	  men	   have	   indicated	   that	   testicular	   volume	  
correlates	   with	   testicular	   function,	   but	   prior	   to	   this	   study	   this	   has	   never	   been	  
shown	   in	   cryptorchid	   boys	   [24,	   97,	   130,	   131].	   Here,	   we	   have	   been	   able	   to	  
demonstrate	  a	  significant	  correlation	  between	  measurements	  of	  testicular	  volume	  
taken	   at	   the	   time	  of	   surgery	   and	   the	  number	  of	   spermatogonia	   and	   Sertoli	   cells.	  
This	   proves	   that	   testicular	   volume	   correlates	   to	   spermatogenesis	   in	   cryptorchid	  
boys	  and	  consequently	  that	  it	  can	  be	  used	  as	  a	  marker	  for	  testicular	  function.	  If	  the	  
difference	   in	   testicular	   size	   between	   early	   and	   later	   treated	   boys	   persists	  




In	   summary,	   early	   orchidopexy	   in	   infancy	   seems	   to	   be	   favourable	   to	   future	  
spermatogenesis,	  but	  the	  data	  on	  testicular	  volume	  show	  that	  even	  though	  partial	  
catch-­‐up	  growth	  occurs	   in	   the	  early	   treated	  boys,	   the	  retained	  testes	  do	  not	   fully	  
reach	  the	  size	  of	  scrotal	  testes.	  	  	  
	  
One	   limitation	  of	   this	  study	   is	   that	  we	  did	  not	  have	  a	  control	  group	  for	  testicular	  
volume,	  and	  we	  were	  unable	  to	  find	  studies	  of	  normal	  testicular	  growth	  that	  could	  
be	  used	  as	  a	  reference	  material	  in	  the	  literature.	  Therefore	  the	  contralateral	  scrotal	  
testes	   in	   the	   unilaterally	   cryptorchid	   boys	   were	   used	   as	   a	   reference	   of	   normal	  
testes	  since	  they	  did	  not	  differ	  in	  size	  from	  any	  of	  the	  groups,	  including	  the	  scrotal	  
testes	  in	  boys	  with	  spontaneous	  descent.	  	  
	  
We	  have	  shown	  that	  already	  at	  birth	  there	   is	  a	  significant	  difference	   in	  testicular	  
volume	   between	   the	   retained	   and	   scrotal	   testes,	   indicating	   that	   prenatal	   factors	  
play	  a	  role.	  Furthermore,	  we	  have	  demonstrated	  that	  the	  longer	  the	  testes	  reside	  in	  
a	   retained	   position	   the	   less	   the	   testicular	   growth,	   thus	   clearly	   showing	   that	   the	  
position	  in	  the	  groin	  has	  an	  adverse	  effect	  on	  testicular	  development.	  In	  support	  of	  
this	  conclusion,	  other	  studies	   indicate	   that	   the	  elevated	   temperature	   in	   the	  groin	  
has	  adverse	  effects	  on	  testicular	  development	  [115,	  118,	  145].	  
	  
However,	  since	  the	  first	  ultrasound	  examination	  in	  our	  series	  was	  done	  during	  the	  
first	  three	  weeks	  of	  infancy,	  it	  is	  possible	  that	  the	  testes	  were	  normal	  at	  birth	  but	  
thereafter	  grew	  less	  than	  their	  scrotal	  counterparts	  resulting	  in	  a	  smaller	  volume	  
at	  the	  time	  of	  the	  first	  ultrasound	  examination.	  	  
	  
We	  hypothesize	  that	  the	  cryptorchid	  position	  with	  subsequent	  higher	  temperature	  
is	  more	  likely	  to	  cause	  adverse	  effects	  if	  the	  testis	  is	  in	  an	  “active	  mode”	  compared	  
to	  a	  cryptorchid	  position	  later	  in	  childhood	  when	  the	  testis	  is	  dormant.	  We	  know	  
from	  published	  volumetric	  results	  in	  studies	  I	  and	  II	  that	  the	  growth	  from	  birth	  to	  
six	  months	  of	  age,	  of	  both	  retained	  and	  scrotal	  testes	  is	  more	  substantial	  compared	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to	   other	   time	   periods	   in	   the	   study.	   In	   other	   words,	   our	   hypothesis	   is	   that	   the	  
testicular	  position	  during	  the	  first	  few	  months	  of	  life	  is	  crucial	  to	  testicular	  growth.	  
This	   is	   supported	   by	   the	   fact	   that	   the	   substantial	   growth	   during	   this	   period	  
coincides	  with	  peak	  levels	  of	  gonadotrophins	  (the	  “mini-­‐puberty”),	  of	   importance	  
for	  testicular	  growth.	  	  
	  
The	   difference	   in	   testicular	   volume	   already	   at	   birth	   is	   interesting	   and	   raises	  
questions:	  Can	  testicular	  growth	  be	  improved	  further	  by	  treating	  cryptorchid	  boys	  
even	  earlier	  than	  at	  nine	  months	  of	  age?	  If	  so,	  how	  soon	  in	  infancy	  would	  treatment	  
be	   required	   for	   the	   previously	   retained	   testes	   to	   catch	   up	  with	   the	   size	   of	   their	  
scrotal	  counterparts?	  Maybe,	  the	  latter	  is	  not	  feasible	  if	  these	  changes	  have	  already	  
occurred	  prenatally.	  On	  the	  other	  hand	   it	   is	  possible	   that	  orchidopexy	  before	   the	  
maturation	  of	  dark	  spermatogonia,	  which	  occurs	  at	  3	  -­‐	  4	  months	  of	  age	  [71],	  will	  
increase	   the	   growth	   of	   the	   retained	   testes	   so	   they	   become	   equal	   in	   size	   to	   the	  
scrotal	  ones.	  	  
	  
Nevertheless,	   if	   we	   undertook	   surgery	   at	   this	   early	   age	   it	   would	   lead	   us	   into	   a	  
clinical	   dilemma	   since	   we	   know	   from	   our	   results	   that	   spontaneous	   descent	   can	  
occur	  as	  late	  as	  six	  months,	  i.e.	  after	  the	  maturation	  process	  to	  spermatogonia	  has	  
taken	  place.	  	  
	  
If	  we	  assume	   that	   the	   spontaneously	  descended	   testes	  are	  normal,	   early	   surgery	  
before	  six	  months	  of	  age	  would	  not	  be	  ethically	  acceptable.	  However,	  in	  this	  study	  
we	   conclude	   that	   the	   growth	   of	   the	   spontaneously	   descended	   testes	   is	   actually	  
impaired	  compared	  to	  their	  scrotal	  counterparts.	  As	  a	  matter	  of	  fact	  we	  have	  found	  
that	  they	  grow	  less	  than	  testes	  treated	  at	  nine	  months.	  	  
	  
We	   can	   only	   speculate	   on	  why	   the	   descended	   testes	   show	   impaired	   growth.	   As	  
demonstrated	   in	   this	   study	   spontaneously	   descended	   testes	   are	   more	   prone	   to	  
ascend	   to	  a	  cryptorchid	  position	  during	  childhood	  (22	  %).	  One	  hypothesis	  about	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the	  impaired	  growth	  is	  that	  some	  of	  the	  descended	  testes	  are	  on	  their	  “way	  back”	  
to	   a	   retained	   position,	   thus	   being	   exposed	   to	   adverse	   conditions	   that	   in	   true	  
retained	  testes	  are	  reflected	  in	  a	  lesser	  volume.	  	  
	  
In	   support	   of	   this,	   other	   studies	   have	   indicated	   that	   testes	   in	   acquired	  
cryptorchidism	   as	  well	   as	   retractile	   testes	   undergo	   adverse	   histological	   changes	  
and	  also	  have	  lesser	  testicular	  volume	  [19,	  25-­‐27,	  117].	  Still,	  from	  our	  point	  of	  view	  
early	   orchidopexy	   during	   early	   infancy	   is,	   despite	   these	   observations,	   not	  
justifiable	  in	  unilateral	  cryptorchidism.	  	  
	  
It	  would	   indeed	   be	   useful	   if	   we	  were	   able	   to	   identify	   endocrine	  markers	   during	  
minipuberty	  in	  cryptorchid	  boys,	  which	  could	  predict	  future	  testicular	  function	  or	  
spontaneous	  descent,	  and	   for	   that	   reason	  we	  analyzed	  different	  hormones	  at	   the	  
age	   of	   two	  months.	   Serum	   inhibin	  B	   is	   considered	   to	   be	   a	  marker	   of	   Sertoli	   cell	  
function,	  but	  studies	  on	  cryptorchid	  boys	  show	  contradictive	  results	  [123-­‐125].	  	  
In	  our	  study	  we	  have	  not	  been	  able	  to	  demonstrate	  any	  conclusive	  hormone	  data	  in	  
early	   infancy	   that	   could	  predict	   future	   spermatogenesis	   or	   spontaneous	  descent.	  
The	  serum	  levels	  of	  hormones	  reflect	   the	  output	  of	  both	  testes	  and	  are	  therefore	  
not	  easy	  to	  interpret	  in	  unilateral	  cryptorchidism	  but	  data	  were	  not	  conclusive	  in	  
bilateral	   cases	   either,	   possibly	   due	   to	   an	   insufficient	   number	   of	   measurements	  
analyzed.	  Consequently	   the	  predictive	  value	  of	   inhibin	  B	  and	  other	  hormones	   for	  
the	  quality	  of	  spermatogenesis	  in	  adulthood	  remains	  to	  be	  established.	  	  
	  
So	   before	   pursuing	   the	   idea	   of	   an	   orchidopexy	   age	   earlier	   than	   nine	  months	  we	  
need	  to	  assess	  whether	  surgical	   intervention	   in	  early	   infancy	  alters	   the	  paternity	  
potential.	  From	  studies	  on	  adults	  with	  a	  history	  of	  unilateral	  cryptorchidism	  it	  has	  
been	   concluded	   that	   fertility	   is	   not	   compromised	   compared	   to	   the	   normal	  male	  
population,	  whereas	  men	  with	  a	  history	  of	  bilateral	  cryptorchidism	  have	  a	   lower	  
paternity	  rate	  [93-­‐95,	  100,	  103,	  107].	  The	  men	  included	  in	  these	  studies	  generally	  
had	  undergone	   surgery	   at	   a	   later	   age	   than	   recommended	   today,	   and	   still	   results	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show	   that	   the	   late	   unilateral	   orchidopexies	   did	   not	   influence	   the	   paternity	   rate,	  
although	  it	  ought	  to	  have	  increased	  the	  germ	  cell	  impairment	  even	  further.	  	  
	  
Since	  men	  with	   a	   history	   of	   bilateral	   cryptorchidism	   have	   compromised	   fertility	  
one	   might	   consider	   treatment	   in	   early	   infancy	   before	   the	   maturation	   of	  
spermatogonia	   takes	   place,	   thereby	   possibly	   improving	   future	   spermatogenesis	  
and	   paternity.	   This	   is	   however	   a	   highly	   speculative	   suggestion,	   and	   long-­‐term	  
follow-­‐up	   studies	   are	   required.	   Nevertheless,	   one	   might	   consider	   operating	  
bilateral	   cases	  on	  one	   side	  early	   in	   infancy	  and	  on	   the	   contralateral	   side	  when	  a	  
spontaneous	  descent	  is	  unlikely	  to	  occur.	  	  
	  
Another	   argument,	   besides	   improving	   fertility,	   for	   treating	   cryptorchidism	   is	   to	  
reduce	   the	   risk	   of	   future	   malignancy.	   Cryptorchid	   boys	   are	   at	   higher	   risk	   for	  
developing	   carcinoma	   in	   situ	   and	   testicular	   cancer	   as	   adults	   [46-­‐48,	   50,	   59].	  
Orchidopexy	  before	  puberty	  clearly	  reduces	  the	  risk	  [56,	  57],	  but	  it	  remains	  to	  be	  
proven	  that	  orchidopexy	  before	  the	  age	  of	  one	  reduces	  the	  risk	  even	  further.	  	  
	  
In	   morphometric	   and	   volumetric	   studies	   with	   five	   years	   of	   follow-­‐up,	   we	   have	  
clearly	  proven	   that	  orchidopexy	  at	  nine	  months	  of	   age	   is	  beneficial	   compared	   to	  
surgery	  at	  the	  age	  of	  three;	  the	  obtained	  results	  clearly	  support	  early	  orchidopexy.	  	  
	  
Before	  recommending	  surgery	  prior	  to	  one	  year	  of	  age	  it	  is	  important	  to	  raise	  the	  
question	  whether	  surgery	  at	  this	  age	  is	  safe,	  both	  in	  regard	  to	  anaesthesia	  as	  well	  
as	  to	  surgical	  complications	  at,	  or	  after,	  surgery.	  The	  Nordic	  consensus	  group	  has	  
concluded	   that	   the	   anaesthetic	   risk	   during	   infancy	   is	   low	   and	   recommends	   that	  
surgery	   should	   be	   performed	   at	   centres	   with	   pediatric	   anaesthesiologists.	  
Furthermore,	   it	   is	   recommended	   that	   pediatric	   surgeons	   or	   urologists	   should	  
operate	  on	  the	  boys	  if	  surgery	  is	  planned	  before	  the	  age	  of	  one	  year	  [20].	   	   In	  our	  
series	  we	   have	   demonstrated	   that	   the	   surgical	  method	   used	   is	   safe	   in	   regard	   to	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complications	  at,	  or	  after,	  surgery	  and	  that	  the	  risk	  of	  atrophies	  and	  recurrences	  is	  
low.	  	  
	  
By	  showing	  that	  spontaneously	  descended	  testes	  often	  will	  ascend	  to	  a	  cryptorchid	  
position	   after	   birth	   we	   have	   proved	   that	   acquired	   cryptorchidism	   exists.	   Other	  
investigators	   have	   concluded	   that	   these	   testes	   undergo	   adverse	   histological	  
changes	  [18,	  19]	  and	  recommend	  treatment	  while	  others	  advocate	  a	  wait-­‐and-­‐see	  
approach	  since	  a	  considerable	  number	  will	  descend	  spontaneously	  by	  puberty	  [9,	  
10,	  15-­‐17].	  However,	  testes	  that	  did	  not	  descend	  required	  surgery	  and	  often	  shown	  
to	  be	  smaller	  than	  the	  contralateral	  testis,	  thus	  indicating	  that	  they	  have	  undergone	  
adverse	  changes,	  reflected	  in	  a	  lesser	  testicular	  size.	  Based	  on	  these	  data	  and	  our	  
own	   findings	   we	   propose	   that	   acquired	   cryptorchidism	   should	   be	   treated	   upon	  
presentation.	  	  
	  
In	   summary	  we	  propose	   the	   following	   criteria	   for	  diagnosis	   and	  management	  of	  




Fig. 20. Schematic decision tree on the management of cryptorchidism, modified from 
the Nordic consensus report [20]. 
	  
Boys	  with	  acquired	  
UDT:	  Refer	  for	  
surgery	  upon	  
diagnosis	  
Boys	  with	  congenital	  
UDT	  >	  6	  mo.	  of	  age	  
Uni/bil	  palpable	  
testes	  
Can	  be	  pulled	  into	  
the	  scrotum,	  
remains	  (>10	  sec.)	  





Can	  be	  pulled	  into	  
scrotum,	  but	  
returns	  in	  less	  than	  
10	  sec.	  after	  30	  sec	  
of	  traction	  
Refer	  for	  surgery	  at	  
6-­‐12	  months	  
Cannot	  be	  pulled	  
into	  scrotum	  




If	  combined	  with	  
hypospadia	  or	  
micropenis	  
Refer	  for	  diagnostic	  
workup	  








8.	  Conclusions	  and	  future	  perspectives	  
The	   main	   objectives	   of	   this	   thesis	   report	   are	   to	   present	   the	   first	   prospective	  
randomized	   study	   on	   the	   timing	   of	   treatment,	   to	   identify	   markers	   of	   testicular	  
function	  of	   importance	   for	   future	  spermatogenesis	  and	   to	   investigate	   the	  growth	  
and	  natural	  course	  of	  the	  spontaneously	  descended	  testes.	  	  
In	   both	   volumetric	   and	   morphology	   studies	   we	   have	   proven	   that	   surgical	  
treatment	  at	  nine	  months	  of	  age	  is	  more	  beneficial	  for	  spermatogenesis	  compared	  
to	   treatment	  at	   three	  years	  of	  age,	   resulting	   in	   improved	   testicular	  growth	  and	  a	  
higher	  number	  of	  germ	  cells.	  	  
	  
Furthermore,	  we	  have	  demonstrated	  that	  testicular	  volume	  correlates	  with	  the	  
number	  of	  germ	  cells,	  thus	  clearly	  indicating	  that	  testicular	  volume	  can	  be	  used	  as	  
a	  proxy	  for	  testicular	  function	  in	  congenital	  cryptorchidism.	  To	  our	  knowledge,	  
this	  has	  never	  been	  proven	  in	  cryptorchid	  boys	  prior	  to	  this	  study.	  
	  
However,	  even	  though	  testes	  were	  surgically	  corrected	  and	  followed	  up	  to	  five	  
years	  they	  were	  still	  not	  showing	  a	  testicular	  volume	  equal	  to	  their	  scrotal	  
counterparts.	  Already	  at	  birth,	  the	  retained	  testes	  had	  a	  smaller	  volume	  
compared	  to	  the	  scrotal	  ones	  indicating	  that	  prenatal	  factors	  may	  play	  a	  role	  for	  
testicular	  volume.	  On	  the	  other	  hand,	  we	  have	  proved	  that	  the	  cryptorchid	  
position	  in	  itself	  has	  an	  adverse	  effect	  on	  testicular	  growth,	  which	  suggests	  that	  
both	  pre-­‐	  and	  postnatal	  factors	  are	  of	  importance	  for	  testicular	  development.	  	  
	  
In	  the	  study	  we	  have	  followed	  boys	  with	  spontaneously	  descended	  testes	  and	  
conclude	  that	  a	  spontaneous	  descent	  usually	  occurs	  within	  the	  first	  months	  of	  life	  
and	  that	  these	  testes	  are	  at	  risk	  to	  ascend	  to	  a	  cryptorchid	  position	  later	  in	  
childhood,	  thus	  proving	  that	  acquired	  cryptorchidism	  exists.	  	  
Interestingly,	  at	  follow-­‐up	  to	  five	  years,	  the	  volumetric	  studies	  show	  that	  the	  
testicular	  growth	  is	  impaired	  compared	  to	  that	  of	  their	  scrotal	  counterparts	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(decreased	  ratio).	  The	  growth	  is	  also	  impaired	  to	  a	  greater	  extent	  than	  testes	  
treated	  at	  the	  age	  of	  nine	  months.	  	  	  
	  
We	  hypothesize	  that	  the	  descended	  tested	  are	  being	  exposed	  to	  adverse	  
conditions	  by	  being	  retractile	  to	  a	  higher	  extent	  than	  scrotal	  testes,	  reflected	  in	  a	  
lesser	  volume.	  	  Based	  on	  these	  data	  we	  have	  presented	  in	  the	  discussion	  a	  
recommendation	  how	  to	  follow	  these	  boys	  clinically.	  
	  
Furthermore,	  we	  wanted	  to	  test	  the	  hypothesis	  that	  hormones,	  analyzed	  
early	  in	  infancy,	  could	  predict	  future	  spermatogenesis	  or	  spontaneous	  descents.	  
The	  data	  collected	  are	  inconclusive,	  and	  therefore	  measurements	  of	  inhibin	  B,	  
gonadotrophins	  and	  testosterone	  could	  neither	  be	  used	  as	  markers	  for	  future	  
testicular	  function	  nor	  to	  predict	  spontaneous	  descent.	  
	  
Results	  from	  the	  surgical	  methods	  used	  in	  our	  series	  show	  that	  the	  open	  inguinal	  
surgical	  approach,	  for	  both	  palpable	  and	  non-­‐palpable	  testes	  in	  infancy,	  is	  an	  
efficient	  method	  for	  achieving	  scrotal	  position	  with	  low	  risk	  for	  atrophies	  or	  
recurrences.	  	  
	  
In	  summary,	  our	  findings	  clearly	  support	  early	  treatment	  in	  congenital	  
cryptorchidism.	  If	  these	  findings	  will	  persist	  into	  adulthood	  and	  affect	  paternity	  
still	  remains	  to	  be	  seen.	  	  
	  
Future	  perspectives	  
Since	   the	  start	  of	   the	  study	   in	  1998	  we	  have	  registered	  more	   than	  4	  000	  clinical	  
visits,	   3	   300	   ultrasound	   examinations,	   2	   200	   blood	   analyses,	   350	   surgical	  
interventions	  and	  260	  biopsies	   in	  more	  than	  450	  boys.	  The	  study	  continues	  with	  
long-­‐term	   follow	   up	   throughout	   puberty	   and	   the	   recruitment	   of	   newborn	   boys	  




In	  the	  near	  future	  we	  will	  present	  genetic	  studies	  on	  familial	  cryptorchidism.	  We	  
have	  identified	  80	  familial	  cases	  and	  a	  number	  of	  mutations.	  Furthermore	  we	  will	  
continue	   the	   morphometric	   studies	   on	   cryptorchid	   boys	   with	   testicular	  
microcalcifications	   and	   its	   importance	   for	   the	   development	   of	   carcinoma	   in	   situ	  
and	  future	  risk	  of	  testicular	  cancer.	  	  
	  
We	   have	   presented	   evidence-­‐based	   recommendations	   for	   the	   management	   of	  
congenital	  cryptorchidism,	  and	  by	  following	  these	  boys	  further	  into	  adulthood	  we	  
have	   a	   unique	   opportunity	   to	   gather	   additional	   data	   of	   importance	   for	   future	  
spermatogenesis	  and	  the	  potential	  to	  shed	  some	  light	  on	  the	  controversial	  issues	  of	  
cryptorchidism	   and	   present	   further	   recommendations	   how	   to	   clinically	   manage	  













Since	  the	  start	  12	  years	  ago,	  this	  study	  has	  been	  like	  a	  long	  and	  often	  very	  inspiring	  
journey.	  The	  work	  has	  indeed	  taken	  a	  long	  time,	  but	  its	  duration	  is	  also	  its	  strength,	  
and	  it	  continues	  to	  have	  a	  great	  potential	  to	  shed	  some	  light	  on	  the	  controversial	  
issues	  on	  cryptorchidism.	  Having	  taken	  part	  of	  more	  than	  4000	  clinical	  visits	  
involving	  more	  than	  450	  boys	  I	  have	  now	  arrived	  at	  the	  point	  of	  writing	  the	  list	  of	  
acknowledgements	  in	  my	  thesis	  book;	  to	  me	  this	  is	  almost	  as	  important	  as	  
presenting	  the	  results	  themselves.	  	  
	  
First	  of	  all,	  I	  would	  like	  to	  dedicate	  this	  book	  to	  all	  the	  boys	  and	  their	  families	  who	  
have	  been,	  and	  still	  are,	  a	  part	  of	  this	  study.	  I	  have	  gotten	  to	  know	  many	  of	  you	  
boys	  personally	  and	  some	  of	  you	  are	  now	  over	  eleven	  years	  old.	  When	  you	  visit	  us	  
for	  a	  check-­‐up	  it	  often	  feels	  like	  meeting	  a	  friend	  and	  I	  am	  really	  looking	  forward	  to	  
meeting	  you	  again	  as	  this	  study	  continues.	  We,	  who	  stand	  behind	  this	  study,	  are	  
proud	  and	  happy	  that	  our	  research	  has	  led	  to	  general	  recommendations	  for	  how	  to	  
treat	  cryptorchidism.	  Still,	  without	  you	  this	  book	  would	  not	  have	  been	  published	  
and	  so	  you	  have	  greatly	  contributed	  to	  the	  medical	  science.	  Thank	  you!	  
	  
Agneta	  Nordenskjöld,	  supervisor	  
Thank	  you	  Agneta,	  for	  accepting	  me	  as	  a	  PhD	  student	  a	  few	  years	  ago.	  Besides	  
being	  an	  excellent	  supervisor	  giving	  guidance	  through	  all	  the	  formalities	  you	  have	  
enthusiastically,	  and	  with	  great	  insight,	  discussed	  everything	  I	  needed	  help	  with.	  It	  
took	  longer	  than	  I	  had	  expected	  to	  finalize	  the	  last	  two	  manuscripts	  up	  to	  a	  point	  
where	  I	  thought	  I	  would	  never	  be	  able	  to	  finish	  the	  thesis	  in	  time.	  But	  you	  have	  
supported	  me	  through	  difficult	  times	  and	  encouraged	  me	  to	  go	  on	  a	  long-­‐planned	  
trip	  to	  South	  America	  just	  a	  few	  weeks	  before	  the	  printing	  of	  the	  thesis.	  	  You	  really	  
believed	  that	  I	  could	  do	  it.	  Thank	  you	  Agneta!	  I	  am	  really	  looking	  forward	  to	  
working	  with	  you	  on	  the	  continuation	  of	  this	  study	  and	  on	  future	  spin-­‐off	  projects.	  	  
	  	  
Martin	  Ritzén	  and	  Olle	  Söder,	  co-­‐supervisors	  
Martin,	  you	  have	  been	  with	  me	  since	  the	  start	  of	  this	  study.	  I	  do	  not	  know	  how	  to	  
thank	  you	  enough.	  You	  amaze	  me,	  not	  only	  by	  being	  a	  scientific	  wizard	  but	  also	  by	  
always	  being	  there	  for	  questions	  and	  discussions.	  No	  matter	  if	  you	  are	  Africa,	  in	  
between	  lectures,	  in	  a	  tennis	  game	  or	  riding	  your	  bike	  to	  work	  (often	  through	  
snow)	  you	  always	  have	  a	  minute	  to	  discuss	  things.	  Olle,	  being	  such	  a	  dynamic	  
person:	  with	  you	  in	  this	  group	  what	  could	  possibly	  go	  wrong?	  	  
	  
Bengt	  Karpe,	  former	  supervisor	  	  
Bengt,	  you	  have	  contributed	  enormously	  to	  this	  thesis	  study	  as	  one	  of	  the	  initiators	  
of	  the	  project	  and	  my	  guide	  through	  the	  first	  two	  publications	  -­‐	  always	  with	  a	  good	  
sense	  of	  humor	  and	  insight.	  	  It	  is	  really	  amazing	  that	  you	  yourself	  were	  a	  PhD	  
student	  having	  Martin	  as	  a	  supervisor	  and	  did	  your	  thesis	  work	  on	  hormonal	  
treatment	  of	  cryptorchidism.	  Even	  though	  you	  are	  retired	  now	  I	  know	  that	  you	  are	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really	  pleased	  to	  see	  this	  publication	  and	  that	  you	  probably	  will	  read	  it	  cover	  to	  
cover.	  	  
	  
Tina	  Granholm,	  former	  supervisor	  
Tina,	  you	  have	  been	  a	  part	  of	  this	  study	  from	  day	  one.	  You	  were	  the	  prime	  initiator	  
of	  this	  project,	  previously	  supervisor	  and	  co-­‐author,	  and	  last	  but	  not	  least	  my	  
roommate	  and	  friend	  giving	  insightful	  advice	  during	  difficult	  times.	  At	  the	  end	  of	  
the	  day	  Tina:	  you	  started	  this.	  	  
	  
Co-­‐authors	  and	  collaborators	  
I	  consider	  myself	  very	  fortunate	  to	  have	  you	  involved	  in	  the	  work	  with	  the	  
publications.	  Thank	  you	  all	  for	  being	  members	  of	  the	  group	  and	  making	  the	  study	  
solid	  as	  a	  rock.	  	  
	  
Ulf	  Hesser,	  you	  know	  of	  course	  that	  you	  have	  been	  a	  co-­‐author	  of	  the	  first	  two	  
publications.	  But	  are	  you	  also	  aware	  of	  having	  done	  over	  3000	  ultrasound	  
examinations?!	  I	  am	  looking	  forward	  to	  working	  with	  you	  in	  new	  projects.	  Thomas	  
Gustafsson,	  you	  have	  contributed	  enormously	  by	  setting	  up	  the	  infrastructure	  for	  
analyzing	  more	  than	  2	  200	  blood	  samples.	  	  
	  
To	  the	  Finnish	  group	  including	  Erno	  Sundqvist,	  Mirja	  Nurmio	  and	  Jorma	  Toppari:	  
without	  your	  collaboration	  on	  the	  morphology	  part	  we	  would	  not	  have	  been	  able	  
to	  draw	  the	  conclusions	  that	  have	  led	  to	  evidence-­‐based	  clinical	  recommendations.	  
I	  learnt	  a	  lot	  about	  morphology	  on	  my	  trips	  to	  Tuurko	  -­‐Thank	  you	  all!	  Jan-­‐Bernd	  
Stukenborg,	  you	  have	  contributed	  greatly	  to	  the	  morphology	  part,	  and	  I	  am	  already	  
looking	  forward	  to	  future	  collaboration.	  I	  would	  also	  like	  to	  thank	  Anders	  Bergh	  in	  
Umeå,	  for	  preparing	  a	  major	  part	  of	  the	  biopsies	  for	  the	  Finnish	  group.	  
	  
Göran	  Läckgren,	  I	  would	  like	  to	  thank	  you	  for	  being	  one	  of	  the	  initiators	  of	  the	  
project.	  During	  many	  years	  I	  have	  had	  interesting	  and	  rewarding	  discussions	  with	  
you	  that	  clearly	  have	  influenced	  my	  view	  on	  cryptorchidism.	  Göran,	  thank	  you	  for	  
contributing	  to	  this	  thesis	  work.	  	  
	  
Pia	  Kjelholm,	  research	  nurse	  
Pia,	  without	  you	  this	  journey	  would	  have	  been	  more	  difficult.	  With	  an	  astonishing	  
capability	  you	  have	  organized	  the	  clinical	  visits,	  blood	  samplings	  and	  ultrasound	  
examinations.	  With	  great	  patience	  you	  have	  explained	  things	  to	  the	  boys	  and	  their	  
families	  and	  sometimes	  persuaded	  them	  to	  continue	  to	  come	  for	  check-­‐ups	  also	  
after	  they	  had	  been	  treated.	  Thank	  you!	  
	  
Colleagues	  
There	  are	  many	  of	  you	  at	  the	  clinic	  that	  I	  would	  like	  to	  thank	  for	  supporting	  this	  
thesis	  work	  in	  different	  ways.	  Some	  of	  you	  have	  encouraged	  me	  along	  the	  way	  and	  
a	  few	  of	  you	  have	  occasionally	  examined	  the	  boys	  when	  I	  was	  not	  available.	  Thank	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you	  all	  for	  your	  help	  and	  support,	  and	  special	  thanks	  to	  you	  PJ	  for	  your	  insight	  and	  
for	  sharing	  your	  thoughts	  with	  me	  when	  I	  needed	  it.	  	  
	  
Lars	  Sundholm,	  mentor	  
Lasse,	  I	  think	  that	  you	  and	  I	  have	  forgotten	  that	  you	  are	  my	  external	  mentor	  in	  this	  
thesis	  work,	  probably	  because	  you	  also	  are	  my	  best	  friend.	  You	  have	  encouraged	  
and	  supported	  me	  from	  day	  one	  with	  personal	  advices	  through	  difficult	  times.	  
During	  the	  last	  three	  weeks	  of	  writing	  you	  have	  completely	  bombed	  me	  with	  
encouraging	  text	  messages	  and	  kept	  me	  laughing	  on	  the	  way.	  	  
	  
Department	  of	  Pediatric	  Surgery	  	  
I	  would	  like	  to	  thank	  the	  Department	  of	  Pediatric	  Surgery	  for	  giving	  me	  the	  
opportunity	  to	  conduct	  this	  work	  and	  finalize	  the	  thesis	  report.	  	  
	  
Sylvester,	  Mauritz,	  Max-­‐Michel	  and	  Anna	  
Sylvester	  and	  Mauritz,	  even	  though	  I	  have	  only	  been	  physically	  present	  for	  the	  last	  
three	  weeks,	  sitting	  on	  the	  couch	  with	  my	  laptop	  writing	  the	  thesis,	  you	  have	  not	  
once	  complained	  about	  me	  being	  mentally	  absorbed	  in	  other	  things	  than	  you.	  On	  
the	  contrary	  you	  have	  encouraged	  me	  to	  continue.	  I	  have	  not	  been	  able	  to	  engage	  
in	  your	  sport	  activities	  they	  way	  I	  usually	  do,	  so	  I	  cannot	  wait	  until	  I	  am	  with	  you	  
on	  the	  soccer	  field	  again	  enjoying	  your	  progress.	  	  
	  
To	  you	  Max-­‐Michel	  I	  would	  like	  to	  say,	  that	  even	  though	  you	  are	  in	  London	  
finishing	  your	  Master’s	  degree	  in	  journalism	  you	  have	  been	  very	  supportive	  in	  
every	  possible	  way,	  constantly	  encouraging	  me	  but	  also	  giving	  me	  advice	  on	  the	  
structure	  of	  the	  thesis.	  I	  am	  very	  proud	  of	  who	  you	  are	  and	  your	  values.	  	  
	  
Anna,	  even	  though	  you	  have	  taken	  care	  of	  everything	  in	  the	  household,	  like	  
emptying	  the	  dishwasher,	  doing	  the	  laundry,	  cooking,	  getting	  the	  kids	  to	  their	  
activities	  and	  helping	  them	  with	  their	  homework,	  you	  have	  kept	  your	  good	  spirits	  
always	  encouraging	  and	  supporting	  me.	  I	  know	  you	  have	  neglected	  doing	  things	  
for	  yourself	  during	  these	  last	  weeks	  and	  I	  am	  looking	  forward	  to	  see	  things	  getting	  
back	  to	  normal	  for	  you.	  Thank	  you	  Anna,	  you	  are	  my	  companion.	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